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SUM MARY
This thesis is concerned with the analysis of cannabinoids, delta-9- 
tetrahydrocannabinol (THC) and its major metabolite, 1 l-nor-9-carboxy-delta-9- 
tetrahydrocannabinol (THCCOOH), in post-mortem blood samples. It concentrates on 
sample preparation procedures and end-step detection techniques by High Pressure Liquid 
Chromatography (HPLC) and Gas Chromatography-Mass Spectrometry (GC-MS).
A comparative evaluation was made of solid-phase (diatomaceous earth, 
Extrelut) and solvent extraction procedures. When extracted with hexane, mixtures of 
hexane and more polar solvents, or acetonitrile, the former gave low extraction yields, for 
example, with acetonitrile the recoveries were 70.4% for THC and 43.9% for THCCOOH. 
It was observed that clogging of the extrelut columns by precipitated blood proteins might 
have resulted in the poor results obtained.
On the other hand, solvent extraction procedures using acetonitrile gave 
better results. Recoveries obtained for THC and THCCOOH were 82.1% and 82.7% 
respectively. These values were found to be higher when deionised water was added to 
dilute the blood samples (83.2% for THC and 86.9% for THCCOOH). However, addition 
of buffers at pH 5.0 and 7.4 did not improve the recoveries obtained by addition of water. 
Calibration curves of the solvent extraction procedure produced linear plots within the 0- 
80ng/ml range for both THC and THCCOOH.
The solid-phase extraction material Bond Elut Certify II was developed 
recently for the extraction and purification of cannabinoids from biological matrices. It was 
incorporated into this study as a clean-up procedure for HPLC analysis of the solvent 
extracts.
Therefore, extraction procedure selected for further analysis involved 
deproteinization and extraction with acetonitrile, supernatant clean-up using the Bond Elut 
Certify II columns, evaporation to dryness and either reconstitution of the residue in mobile 
phase for HPLC analysis or derivatization of the residue prior to GC-MS analysis.
For HPLC analysis, acetonitrile-methanol-0.02N sulphuric acid (65:15:50, 
v:v:v) was chosen from four mobile phases examined. Detection o f analytes was carried 
out using ultra-violet (UV) and electro-chemical (ECD) detectors at wavelengths 212nm, 
220nm and at an applied potential of +1.10V respectively, after detector optimisation 
procedures. The clean-up procedure separated the cannabinoids into THC and THCCOOH 
fractions. Thus, two internal standards were needed for quantitation purposes. N-octyl p- 
hydroxy benzoate and phenylbutazone were found to be the most suitable choices for the 
two fractions, respectively. It was also observed that the THC fraction gave clean 
chromatograms while the THCCOOH fraction contained co-extracted interferences which 
eluted closed to the metabolite.
Average recoveries for THC, cannabidiol (CBD), cannabinol (CBN) and 
THCCOOH by this HPLC system were 91.1%, 93.6%, 90.1% and 91.4% detected by UV 
212nm; 88.9%, 93.5%, 88.9% and 90.7% by UV 220nm and 93.4%, 94.7%, 98.7% and 
89.1% by ECD +1.10V, respectively. Calibration curves were linear from 0-100ng/ml for 
both UV detection wavelengths, and within the range 0-200ng/ml for ECD detection. 
When eight test samples were analysed, which were positive when screened for 
cannabinoids by radioimmunoassay, none of the samples gave positive results for THC and 
CBN. Electrochemical detection but not UV detection gave five samples positive for CBD, 
while THCCOOH was found to be present in all of the test samples.
GC-MS analysis was performed under full scan, selected ion recording 
(SIR), multiple reaction monitoring (MRM) and negative ion chemical ionisation (NICI)
modes. Extracted samples were not cleaned up with Bond Elut Certify II in order to 
evaluate the sensitivity and selectivity of the different GC-MS modes. Full scan mass 
spectra of THC, THCCOOH and their derivatives were compared. They were found to 
produce parallel series of ion fragments through similar fragmentation mechanisms.
Analyses by SIR-MS were performed to confirm the identity of the analytes 
in blood extracts. Calibration curves for THC and THCCOOH were linear from 0- 
lOOng/ml. When the same eight test samples were analysed, three of them were found to 
be positive for THCCOOH, but only two of the samples gave positive results for THC. In 
the MRM mode, the transitions to the most prominent daughter fragments [M-15]+ formed 
by the parent analytes, THC and THCCOOH, were monitored. Linear calibration curves 
were obtained within the range 0-100ng/ml. Analysis of test samples showed that two 
samples were positive for both analytes, while another two samples were found to be 
positive for either THC or THCCOOH. Interference was observed for THC in the other 
four samples. This interference was also observed under NICI mode and all analyses for 
THC by NICI selected ion recording were unsuccessful. Case samples also suffered from 
the presence of interferences and could not be quantified.
In conclusion, the optimum method established in this study was acetonitrile 
extraction of blood samples followed by GC-MS in E l(+) selected ion recording mode used 
as the end-step analysis. Sample clean-up is not essential but would help in prolonging the 
column life.
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AIMS OF STUDY.
Modem techniques provide an oppurtunity to detect low levels of 
cannabinoids in body fluids. However, only a few published methods have dealt with 
routine screening and subsequent confirmatory analysis in whole or hemolysed blood 
samples, which are the most common form of exhibit material received in forensic 
toxicology laboratories. This analysis still poses problems because of interference caused 
by co-extracted blood components. Thus, the object of this study was;
(a) to compare and evaluate suitable extraction and clean-up techniques for delta-9- 
tetrahydrocannabinol and its metabolite, 1 l-nor-9-carboxy-delta-9- 
tetrahydrocannabinol in whole blood,
(b) to evaluate two methods of analysis of the extracts which are suitable for routine 
laboratory use i.e. high-pressure liquid chromatography (HPLC) with non-specific 
but sensitive ultra-violet and electrochemical detectors, and also the more costly and 
technically demanding technique of gas chromatography-mass spectrometry (GC- 
MS), which offers high specificity and sensitivity in selected ion recording, 
metastable ion monitoring nad negative ion chemical ionisation detection modes; 
and finally,
(c) to evaluate the methods for use with authentic case samples.
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CHAPTER 1, CANNABIS : AN OVERVIEW.
1.1 History.
The hemp plant and its products have been a valuable source for man's 
commercial, medical, religious and recreational use for thousands of years. For instance, 
its oil can be used in the composition of paint and varnish, its fiber can be made into rope, 
twine and bags, and the biologically active constituents can be used as relaxants and mild 
intoxicants.
Historians claim that cannabis was first used therapeutically in the Chinese 
and Indian cultures as an antiseptic and analgesic. Other medical uses were later developed 
and spread throughout the Middle East, Africa and Eastern Europe. It only became widely 
accepted by Western medical practitioners several years after the return of Napoleon's army 
from Egypt. However, cannabis began to lose the support of the medical profession in the 
latter half of the 19th century due to the growing superiority of other medications used in 
relation to their effects and more easily controlled as to dose.
In the early 20th century, perception of cannabis changed from that of being 
medically acceptable to being socially disreputable. Strong public reaction resulted in 
cannabis being "illegal" in many countries. Hence, cannabis drugs are generally regarded 
as obsolete and are rarely employed nowadays. In the United Kingdom under the Misuse 
of Drugs Act (1971), cannabis is considered to have no valid medical uses. Nevertheless, 
many U.S. drug companies are attempting to synthesize new analogs of 
tetrahydrocannabinol (THC) with the aim of developing some clinical useful preparations. 
As a result, delta-9-THC has recently re-appeared as an anti-emitic during chemotherapy in 
the United States.
1.2 Chemistry.
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The plant material is quite complex, containing at least 421 individual 
compounds, where 61 of them have been identified as cannabinoids^). These include the 
principally psychoactive delta-9-tetrahydrocannabinol (delta-9-THC), its isomer delta-8- 
tetrahydrocannabinol (delta-8-THC), cannabidiol (CBD) and its by-product, cannabinol 
(CBN). Table 1.1 lists some of the chemical constituents found in cannabis.
When smoked, some of the chemicals contained are further transformed by 
pyrolysis into still other compounds. All but delta-8- and delta-9-THC, delta-9-THCV 
(delta-9-fran.s-tetrahydrocannabivarin) and CBN are psychomimetically inactive 
com pounds^), but several studies seem to indicate that some materials present in natural 
marihuana may act synergistically with THC and potentiate its psychologic effec t^).
The existence of two numbering systems confuses the chemical 
nomenclature of tetrahydrocannabinols. The monoterpenoid system considers the 
compounds as substituted terpenes (delta-1-THC) while the formal dibenzopyran system 
treats them as substituted dibenzopyrans (delta-9-THC). The formal system will be used 
hereafter (Figure 1.1).
11 (B)
: ^ \ l 0  PH
Figure 1.1 : Numbering Systems of Delta-9-Tetrahydrocannabinols. 
(A) M onoterpene (B) Dibenzopyran
Table 1.1 : Chemical Constituents Found in Cannabis. ^
Chemical Constituents No. of Types Kn
1. Cannabinoids 61
a) Cannabigerol (CBG) 6
b) Cannabichromene (CVC) 4
c) Cannabidiol (CBD) 7
d) Delta-9-Tetrahydrocannabinol
(Delta-9-THC) 9
e) Delta-8-Tetrahydrocannabinol
(Delta-8-THC) 2
f) Cannabicyclol (CBL) 3
g) Cannabielsoin (CBE) 3
h) Cannabinol (CBN) 6
i) Cannabinodiol (CBND) 2
j) Cannabitriol (CBT) 6
k) Miscellaneous 9
1) Others 4
2. Nitrogenous compounds 20
a) Quaternary bases 5
b) Amides 1
c) Amines 12
d) Spermidine alkaloids 2
3. Amino acids 18
4. Proteins, glycoproteins, and
enzymes 9
5. Sugars and related compounds 34
a) Monosaccharides 13
b) Disaccharides 2
c) Polysaccharides 5
d) Cyclitols 12
e) Amino sugars 2
6. Hydrocarbons 50
7. Simple alcohols 7
8. Simple aldehydes 12
9. Simple ketones 13
10. Simple acids 20
11. Fatty acids 12
12. Simple esters and lactones 13
13. Steroids 11
14. Terpenes 10 3
a) Monoterpenes 5 8
b) Sesquiterpenes 38
c) Diterpenes 1
d) Triterpenes 2
e) Miscellaneous compounds of
terpenoid origin 4
15. Noncannabinoid phenols 16
16. Flavanoid glycosides 19
1.3 Botany.
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Cannabis sativa L. or Indian hemp, ia a tall, annual, bushy plant that can be 
grown in any region with hot summers. It is widely distributed throughout the temperate 
and tropical zones of the world and is probably the oldest non-food plant ever cultivated.
Cannabis is a dioecious species with separate male and female plants, both 
producing flowers. The activity of the plants was about the same because the female plants 
yielded more but less potent resin than the male p la n ts .^  The drug content of the plant 
parts is variable. Generally, it decreases in the following order: bracts, flowering tops, 
leafy tops, small leaf, large leaf, stem. Practically no cannabinoids are found in the roots or 
seeds.
The plant can also be classified generally as either drug or fibre genotype. 
The drug type is high in THC but low in CBN and the fibre type is the converse. The 
intermediate cannabis has the percent by dry weight of CBD equal to or slightly greater 
than delta-9-THC. Cannabichromene (CBC) is always present in drug types.
The concentration of cannabinoids in the plant is a function of genetic and 
environmental factors (type of soil, water, temperature, growing space). Other factors 
include the time of collection (maturity of the plant) and the treatment of the sample taken 
(drying, storage, extraction and analysis).
Marihuana, bhang, ganja, kif and maconha are among the commonly used 
names for cannabis or its products in various countries. Differences in names refer to 
differences in the mixture of the leaves and flowering tops of the plant. For example, 
marihuana consists of the dried and crumbled stems, leaves and seed pods of the female 
plant. Bhang consists of specially dried leaves and flowering shoots of both male and
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female plants, wild or cultivated, while ganja refers to a specially cultivated hemp plant that 
contains an unusually large quantity of active materials.
Meanwhile, hashish or charas are names often applied to the pure 
unadulterated resin from the top of the finest female plants of Indian hemp which also 
contains a very high concentration of active constituents. Less common and strongest of 
all, is cannabis oil or hash oil, a liquid prepared from the resin.
1.4 Routes of Administration.
The plant is usually cut, dried, chopped and rolled up into a cigarette and 
smoked, often combined with tobacco. It can also be smoked in a pipe, brewed into a drink 
or cooked in foods.
Conversion of THC precursor acids to active THC during marihuana 
smoking may activate and increase the potency of a cigarette, and a similar process may 
occur during the baking of brownies and other forms of cooking with marihuana plant 
m ateria l^), although prolonged heating may destroy THC. Approximately 50% of the 
THC in a cigarette is absorbed by the lungs if the entire cigarette were smoked in ten 
minutes and each inhalation were retained for 30 seconds with no side-stream l o s s / ^
Generally, the effects produced by ingested THC or ingested marihuana 
extract are comparable to those produced by nearly one third the amount of smoked and 
inhaled THC or m a r i h u a n a ^ ) .  Perez-Reyes et al.*^ indicated that it is the rate of THC 
absorption, and the duration of its action which is affected by the chosen route of 
administration.
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Lemberger et al.(^) observed that by administering radiolabelled THC, the 
greatest and most prolonged radioactivity in the bloodstream was obtained following 
inhalation of smoke from spiked marihuana and the least after oral ingestion.
In addition, studies conducted by Cone et a l . ^  and Law et a l . ( ^ )  on the 
oral ingestion of THC showed behavioral and physiological effects similar to those 
produced from smoking marihuana cigarettes, but the onset and peak effect was delayed 
and the duration of effect was extended.
1.5 Metabolism.
Absorbed slowly and incompletely by the stomach, delta-9-THC is much 
more effective when smoked and absorbed by the lungs. It reaches a maximum blood level 
within a few minutes and then falls rapidly, due to metabolism and tissue storage, to 
approximately 10% of its peak concentration within the hour. The concentration of THC 
after this time normally being no more than a few nanograms per millilitre of blood. 
Figures 1.2 to 1.5 show the metabolic pathways of delta-9-THC, delta-8-THC, CBD, and 
CBN.
Agurell et a l . ^ ^  developed a method to identify and measure accurately 
nonlabelled delta-9-THC in the plasma of cannabis smokers. Results showed that within 10 
minutes of smoking a cigarette containing lOmg of delta-9-THC, peak plasma levels of 19- 
26ng/ml were reached and later declined rapidly to < 5ng/ml within 2 hours.
- 7 -
C H O  ► C O O H  ► Glucoronide
C H 2OH
cxHO
Glutathione conjugate
O H  ► Glucoronide
(CH2)nCOOH
Figure 1.2 : Metabolic Pathways of Delta-9-THC.
ChfeOH^
Fatty acid conjugate
C O O H
^  Glucuronide
(C H 2)nC O O H
► O H
Figure 1.3 : Metabolic Pathways of Delta-8-THC
C H 2 O H  ► C O O H
OH ► Glucuronide
(C H 2 )n C O O H
Figure 1.4 : Metabolic Pathways of Cannabidiol.
C H 2 O C O R
► C O O H► C H OCH 2 OH
O H  ► Glucuronide
OH
► OH
(C H 2)n C O O H  O H
Figure 1.5 : Metabolic Pathways of Cannabinol.
O C O R
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Based on the chemistry of the phenolic group common to all cannabinoids, 
cannabinoid-like drugs and their metabolites, Rosenfeld et a l . ( ^ )  developed and applied a 
mass fragmentographic assay for delta-9-THC in plasma of human volunteers. Results 
obtained were similar to those reported by Agurell et a l.^
L e m b e r g e r ^ )  indicated that THC disappears from plasma in two phases. 
The initial rapid phase has two components and represents metabolism by the liver and 
redistribution from the blood to the tissues. The slower, second phase represents tissue 
retention and slow release and subsequent metabolism. THC is essentially insoluble in 
water and is protein bound.
Initial metabolism of cannabinoids from cannabis smoke or from orally 
consumed cannabis takes place in the lungs or in the liver, respectively. Since different 
enzymes are involved, different initial metabolites are produced. Major lung metabolites 
are usually hydroxylated derivatives of the cyclohexene ring s y s te m ^ )  However, the 
major one is undoubtedly 1 l-nor-9-carboxy-delta-9-THC (THCCOOH) produced via the 
11-hydroxy THC metabolite.
THC is rather unstable, being degraded by heat, light, acids and atmospheric 
oxygen, properties that account for the well known tendency of cannabis preparations to 
lose potency on s t o r a g e . I t s  terminal plasma half-live is 28-56 hours and has been seen 
to be significantly shorter in daily users than in nonusers. Urinary excretion and biliary 
excretion (reflected a day later in the faeces) was found to be greatest during the initial 24 
hours, then gradually tapering off. Law et a l . ^ ^  pointed out that following a single, 
moderate, oral dose of cannabis resin in a meat sandwich (20mg delta-9-THC), significant 
concentrations of cannabinoid metabolites were detected in plasma samples for up to 5 days 
and in urine samples for at least 12 days.
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1.6 Dose and Effects (Pharmacodynamics).
Pharmacologic actions of cannabis are highly subjective and are affected by 
a number of variables such as the quality of the drug, the dosage, the experience and 
expectations of the user and his environment.
The psychomimetic activity due to inhalation or ingestion of low doses 
(25ug/kg) of delta-9-THC may cause euphoria, relaxation, talkativeness, bouts of hilarity 
and sensory enhancement. Larger doses (250ug/kg) will give an intense hallucinogenic 
experience, perceptual distortion, temporal disintegration, confusion and can be distressfull.
Unlike the smoking route in which peak behavioral and physiologic effects 
occur within minutes after smoking, responses after ingestion of THC have a slower onset 
and greater variability with maximum effects occuring 1.5 to 3.5 hours later. This slow 
onset of effects is consistent with results reported by Perez-Reyes et a l . ^ ,  Ohlsson et 
a l .( ^ ) ,  and Law et a l . ^ ^
The most common physical responses to cannabis are an increase in pulse 
rate and reddening of the eyes. Also reported are dryness of the mouth and throat due to the 
irritancy of cannabis smoke. Its effects are more prominent on the central nervous system 
and the cardiovascular system. However, deaths due to an overdose of cannabis are rare 
and usually relate to large oral doses. The minimum fatal dose by oral injestion of charas, 
ganja and bhang was 2, 8 and lOng/kg of body weight respectively .^) The lethal dose of 
delta-9-THC, receiving intravenously, is 30mg/kg of body w e i g h t . ^ )
Agurell et a l .( ^ )  pointed out the pharmacokinetics of delta-8-THC in man 
after smoking and the relationship of blood levels to physiological and psychological 
effects. It was shown that the increase in heart-rate was well correlated with the delta-8-
-11 -
THC plasma levels but the alterations in mental performance were more delayed and 
prolonged than the peak plasma level.
Hollister et a l .( ^ )  used 11 volunteers to address the question of whether 
THC levels reflected the state of cannabis intoxication. The volunteers were given about 
19mg THC by smoking, 20mg THC orally and 5mg THC i.v. The THC plasma levels were 
measured up to 4 hours after administration by GC-MS. They concluded that the 
relationship between pulse rate and plasma concentration of THC was similar to that 
reported by Agurell et a l .( ^ ) ,  but they saw no clear-cut relationship between plasma 
concentrations of THC and the degree of intoxication, in contrast to the case for ethyl 
alcohol.
TABLE 1.2 : SUMMARY OF THE RELATIONSHIP BETWEEN DOSES AND 
EFFECTS OF CANNABIS ADMINISTRATION.
Doses Effects References
Delta-9-THC, ingestion 
300-480ug/kg or 
smoking 200-250ug/kg. 
10 subjects.
Marked distortion of visual & auditory 
perception and hallucination occurred 
in most subjects.
(19)
M arihuana extract, 
66mg/kg of body weight. 
12 subjects.
Produced a mild "high" in all subjects 
Reaction time & digit code memory 
tasks impaired.
(20)
THC, 4.5mg & 18mg, 
smoking. 9 naive 
subjects.
Impairment in simple intellectual and 
psychomotor performance tests
(21)
THC, lOmg, smoking Significant decrements in human motor 
and mental performance.
(22)
THC, 15-25mg, ingestion 
or 5-10mg, smoking
Significant impairment of motor and 
mental performance
(23)
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Cannabis is not physically addictive. Thus, abstinence or abrupt cessation of 
intake will not produce distinct withdrawal symptoms. The relationship between different 
doses and effects of cannabis is briefly summarized in Table 1.2. In relation to impairment 
of motor and mental performance, the dose and effect relationship is briefly summarized in 
Table 1.3.
TABLE 1.3 : SUMMARY OF DOSES AND EFFECTS OF MARIHUANA'S 
RELATIONSHIP IN RELATION TO PERFORMANCE IMPAIRMENT.
Doses Effects References
Marihuana, 1.7g 
(1.3% THC) smoking 
36 subjects.
Significantly more speed errors on 
driving simulator
(24)
Delta-9-THC, 3.3 & 
6.6mg smoking.
10 experience and 
10 naive subjects.
Equal impairment in driving performance (25)
Delta-9-THC, 350, 
400 & 450ug/kg 
orally 54 subjects.
Impairment of attention and concentration 
capacities, prolongation of reaction time, 
increased frequency of wrong and 
inadequate responses, and smooth 
automation disturbances.
(26)
Delta-9-THC, 18mg, 
smoking. 58 subjects.
General impairment in Roadside Sobriety 
Tests.
(27)
Delta-9-THC, 6.3mg, 
smoking.
3 Professional and 
3 private pilots.
Deterioration in Hying performance. (28)
THC, 0.09mg/kg, 
smoking.
10 certified pilots.
Significant deterioration in simulated 
instrument Hying ability.
(29)
THC, 19mg, smoking. 
10 private pilots.
Performance decrements on flight 
simulator.
(30)
1.7 Light vs Heavy Users.
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Lindgren et a l . ( ^ )  determined the plasma concentrations of THC given by 
smoking and i.v. administration to groups of light and heavy users of marihuana. The 
subjects were given marihuana cigarettes containing about 19mg THC or an i.v. dose of 
5.0mg THC. Their smoking experiments were unable to determine any significant 
difference in plasma levels of THC between light and heavy users. But, they did note a 
tendency that heavy users showed higher THC levels suggesting more efficient smoking 
than light users.
Similarly, Perez-Reyes et a l . ( ^ )  too found no differences in total plasma 
radioactivity or the amount of 1 4 C-THC needed i.v. to produce a maximal "high" in 
infrequent and frequent marihuana users. So far as maximal "high" is concerned, both 
studies found no difference in light vs heavy users and neither sensitivity nor tolerance to 
THC was observed.
Wall et a l . ( ^ )  pointed out the extensive biotransfonnation of various 
cannabinoids in animals and man. They stressed the fact that due to some active 
metabolites of THC, no simple relationship between plasma levels and marihuana induced 
"high" would be expected.
Ohlsson et a l.^ 4 ) studied the single dose kinetics of deuterium-labelled 
THC in light and heavy cannabis users by both smoking and i.v. administration. Plasma 
levels of 2 H 3 -delta-9-THC were measured for 48 to 72 hours. The results showed little 
difference between the groups with regard to the amounts absorbed from the smoke, plasma 
levels or areas under the plasma concentration vs time curves. Thus, as in previous studies, 
no evidence was obtained for either sensitivity or tolerance to THC in heavy users.
1.8 Passive Inhalation.
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Plasma concentrations of THC near the detection limits of most analytical 
methods may possibly be produced by either passive inhalation or from active cannabis 
smoking that occurred at some time earlier. The former may occur as demonstrated by the 
presence of THC in blood and cannabinoids in blood and urine of passive smokers.(35-40)
This presents a threat to the passive inhaler because secondary smoke too 
contains psychoactive delta-9-THC and other cannabinoids. However, the degree of threat 
depends on several factors which include the amount of cannabis smoked by the active 
user, the duration and frequency of exposure, the room size and ventilation conditions and 
the individual metabolic factors of the passive inhaler.
A study done by Morland et a l . ( ^ )  showed that the highest concentration of 
plasma THC reached by passive inhalation was 13ng/ml which corresponds to the 
concentration measured in plasma approximately 30 minutes after active smoking of 15mg 
of THC.
Is there any way to distinguish between active and passive smokers? Mason 
et a l . ( ^ )  suggested that it is possible to differentiate between them by determining the 
relative concentrations of 9-carboxy-THC and THC in plasma at different times. This is 
because their inhalation experimental findings showed that the concentration of 9-carboxy- 
THC was consistently less than the concentration of THC determined by GC-MS analysis, 
whereas the literature indicated that within 20 to 30 minutes after the initiation of active 
cannabis smoking, the concentration of 9-carboxy-THC becomes greater than the 
concentration of THC in plasma and remains higher for many hours.
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Another method for avoiding unfair penalisation of passive smokers is to set 
up a cut-off level. For urine THC metabolites analysis, it is recommended to set up a cut­
off level at about 2 0 ng/ml, after considering the results of studies of passive smoking of 
THC under several conditions, as shown in Table 1.4. But, under extremely heavy passive 
smoking conditions, the distinction between active smoking and passive inhalation could be 
lost.
TABLE 1.4 : SUMMARIES ON STUDIES ON THE PASSIVE 
INHALATION OF THC.
THC
burn
(mg)
Room
size
(L)
Exposure
time
(h)
Sample/
Compound
Detection/
Sensitivity
References
52 15,500 1 urine
cannabinoids
EMIT
Ong/ml
(36)
52 large
car
1 urine
cannabinoids
EMIT
2 0 ng/ml
(36)
104.8 15,500 1 plasma
9-THCCOOH
RIA
<3ng/ml
(35)
103 27,950 3 urine
metabolites
RIA
<7ng/ml
(37)
27 ( 1 0 x 1 0 )
inches
0.25
0.50
saliva
THC
RIA/18ng/ml
RIA/Ong/ml
(38)
90 small
car
0.50 blood
THC
GC/MS
<7ng/ml
(34)
98 12,226 1 urine
cannabinoids
THCCOOH
THCCOOH
EMIT/<7ng/ml 
GC/MS<26ng/ml 
RIA/ <42ng/ml
(39)
398 12,226 1 urine
cannabinoids
THCCOOH
THCCOOH
EMIT/<7 lng/ml
GC/MS<90ng/ml
RIA/<145ng/ml
(39)
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1.9 Stability of Cannabinoids in Body Fluids.
A number of studies on the stability of THC in body fluids during storage 
have been published. Wong et a l .( ^ )  evaluated the effects of long-term storage on the 
concentrations of THC in blood and serum stored between -20 and 5°C. They found that 
THC concentrations in blood and serum samples had decreased markedly after 17 and 19 
weeks respectively.
The stabilities of THC and two of its metabolites, 11-hydroxy-THC and 
THCCOOH, were studied by Johnson et a l . ( ^ )  in blood and plasma stored at -10, 4°C 
and room temperature. Their results are similar to those reported by Wong et a l .^ l )  for 
storage periods up to 17 weeks. However, after 26 weeks of storage at room temperature, 
the concentrations of THC and 11-OH-THC in blood and plasma were significantly lower, 
but the THCCOOH concentration did not change.
While THC in dry form, chloroform, hexane and carbon tetrachloride 
deteriorated about 10% each month, it was reasonably stable for more than 75 days at room 
temperature and for more than one year at 0-5°C when stored in ethanol solution. (43)
In addition, since THC is a lipophilic molecule and tends to bind readily to 
hydrophobic surfaces, its concentration will be greatly reduced if stored in certain types of 
containers. This is supported by results obtained from Garrett and H u n t ^ ) ,  who reported 
absorption of THC to rubber stoppers, but in unsilanized glass, its absorption was 
apparently prevented by proteins in blood that bind over 97% of THC. However, in the 
study cited above, Johnson et a l.^ 2 ) found no absorption to rubber stoppers in their blood 
collection tubes.
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C hristophersen(^) investigated the stability of THC in whole blood during 
storage in unsilanized glass vials with rubber septa and in plastic polystyrene tubes over 4  
days and 4 weeks at room temperature and -20°C respectively. He noted that blood 
concentrations of THC were stable in the glass vials, but 60-100% of THC stored in the 
plastic tubes was lost. Even the recovery of internal standard from plastic tube samples was 
low, varying from 30-50% of the value in the corresponding glass vial samples. These 
losses were due principally to absorption to the plastic that could not be prevented by 
binding proteins in the blood. Thus, it is advisable and important to carry out stability tests 
for biological samples in the actual containers used in each laboratory and with the same 
sample handling and storage procedures used for real samples.
1.10 Forensic Toxicology.
The toxicity of marihuana is low and fatalities due to its poisoning are very 
rare. It is impossible to prove anything safe, but smoking marihuana appears to be safer 
than overindulgence with alcohol, tobacco, barbiturates, heroin, aspirin, and many other 
drugs.(46) This is because deaths and withdrawal symptoms attributed to heroin, alcohol 
and barbiturates do not occur with marihuana. Moreover, respiratory diseases and cancer 
associated with chronic marihuana smoking have not been reported and cardiac effects of 
caffeine of coffee, tea and soft drinks have not been attributed to marihuana.
In addition, there is no conclusive evidence that short-term marihuana use 
alone directly results in any physical damage to h u m a n s .^  Many fatal overdoses are 
caused by drug interactions due to consumption of cannabis with other drugs. Cannabis has 
been shown to alter the effects of alcohol, barbiturates, benzodiazepines, nicotine, 
amphetamines, cocaine, phencyclidine (PCP), opiates and other d r u g s . T h i s  alteration
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will enhance or prolong behavioral, physical and psychological effects, thus may result in 
fatalities such as road accidents, drowning, fires and injuries due to falls or fights.
1.11 Conclusion.
It is frequently of considerable concern to know whether someone was under 
the influence of cannabis at the time of his death. Since circulation ceases at death, the 
metabolism of delta-9-THC in the liver would be expected to be halted and the levels 
determined by analysis should reflect those present at death. Thus, this definitive 
identification in blood from an autopsy sample presents direct and unquestionable evidence 
of the deceased's use of this drug.
Development of improved methods gives an opportunity to detect and 
estimate low levels of delta-9-THC or its metabolites. However, only a few have dealt 
directly with the development of reliable methods for the routine screening and subsequent 
confirmatory and quantitative analysis in whole or hemolysed blood samples. Because of 
the forensic nature of this study, its objective was therefore to develop screening, 
confirmatory and quantitative methodologies for the analysis of cannabinoids in autopsy 
blood samples.
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C H A PT E R  2. EX PER IM EN T AT, REVIEW .
2.1 Introduction.
For forensic purposes, analysis of cannabis drugs of abuse can be divided 
into three operations: screening, identification and quantitation of the cannabis materials or 
products in question. Many studies have been extensively pursued, but most of them have 
been developed for plasma and urine from living patients or volunteers.
The major problem in the development of an accurate method is that active 
physiological levels of cannabis, particularly delta-9-TFIC, are usually quite low, rarely 
exceeding lOOng/ml of whole b l o o d .^ ’4^) Autopsy samples are most likely to be lower 
than this and clear plasma is never available. Thus, sensitive methods are needed which 
should also be specific and characteristic for delta-9-THC, to be valid in forensic science 
applications.
Analysis of cannabinoids in autopsy samples may also be considered as two 
parts: ( 1 ) extraction and clean-up procedures, and (2 ) the end-step analysis which may also 
involve derivatisation, depending on the instrument used.
2.2 Sample Preparation.
2.2.1 Urine Hydrolysis.
The major metabolite of THC in urine is THCCOOH, which exists in both a 
free acid or a conjugated glucuronide form. Thus, prior to extraction, the urine sample 
should be decomposed by hydrolysis to convert the conjugated metabolite to the free acid
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form for extraction. Most hydrolysis steps involve the use of potassium hydroxide (KOH) 
or beta-glucuronidase, processes known as alkaline or enzyme hydrolysis respectively. 
Among those who used alkaline hydrolysis were Nakahara et al.(5°), Karlsson^51), Parry et 
a l / 52)and Meatherall and Garriott(53), while Kanter et al.(54), McBumey et al.(55) and 
Craft at al.(3^) used the enzyme to hydrolyse their urine samples.
2.2.2 Blood (Plasma/Serum) Pretreatment.
Because THC and its metabolites bind strongly to blood proteins, it is 
difficult to extract them completely. A deproteinization step is necessary to improve 
extraction efficiency. Nakahara et al.(37) have evaluated the recoveries of THC 
metabolites obtained in plasma after deproteinization with various solvents, and results 
showed that acetonitrile-pyridine ( 1 0 : 1 ) gave the highest recoveries while 1 0 % 
trichloroacetic acid gave the lowest recoveries.
2.2.3 Solvent Extraction.
Extractions by solvents (liquid-liquid) are most commonly used since many 
solvents can extract THC and its metabolites from plant materials and body fluids. But it 
has been shown that hexane alone extracts cannabinoids very efficiently and in some cases 
gives clean extracts suitable for direct analysis by gas-phase techniques.(45,53,58-62) 
However, some extraction techniques used single solvents such as ether(34  ^aceton itrile^3' 
and a c e to n e ^ ) ,  while others used mixed solvents such as hexane-ethyl acetate 
and heptane-isoamyl a l c o h o l . ^ 7_69)
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2.2.4 Solid-Phase Extraction.
Solid-phase extraction (SPE) has emerged as a powerful tool for chemical 
isolation and purification, where the analyte is selectively absorbed from the biological 
matrix on to one of a variety of commercially available solid phases (eg. silica or bonded 
silica) contained within a disposable cartridge. The use of SPE columns has gained 
popularity over recent years due to reported excellent recoveries and ease of use. 
Furthermore, its advantages include the simultaneous extraction of a number of samples, 
the prevention of emulsion formation as often occurs with solvent extraction, rapid sample 
preparation, removal of evaporation steps and potential automation.
There are many types of SPE depending on the specific properties of the 
bonded cartridge. Schermann et a l . ^ ^  and H a t t o r i ^ l )  have used a diatomaceous earth 
(Extrelut) column to extract urinary and blood cannabinoids respectively, while Craft et 
ah(56), pohz et a l . ^ ^  and Zweipfenning et al.(7 -^ have extracted cannabinoids using 
bonded-silica C 1 8 columns. However, Parry et al.(-^) have recently reported a procedure 
using Supelclean DrugPak-T SPE (anion exchange) tubes for the isolation of THCCOOH, 
where they obtained an absolute recovery of greater than 85% for the metabolite from a 
urine sample matrix.
2.2.5 Clean-up Procedure.
Some extracted samples do contained coextracted interferences such as 
endogenous urine compounds or blood lipids. These will result in lower extraction 
recoveries and detection limits. Thus, extensive sample clean-up procedures are essential 
in most chromatographic assays, especially HPLC, in order to prevent ruining the 
octadecasilica (ODS) column used during the analysis. Clean-up procedures are usually 
based on some form of wet chromatography such as TLC, as used by Bachmann et a l / 74^
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or HPLC as used by Garrett and Hunt^73) and Peat et al.(7^) Others have also used column 
clean-up like C 18 columns^63) and Sephadex LH - 2 0  columns . ^ 1 ! ’66)
2.3 End-Step Analytical Methods.
It is important that cannabinoid assays should be specific and sensitive. If 
these are achieved, the assays can avoid lengthy clean-up and derivatisational procedures.
2.3.1 Thin Layer Chromatography (TLC).
Separation of cannabinoids by TLC is difficult because of the close 
similarity in structure between the different compounds, and it is much more difficult to 
detect and measure them in biological fluids. Silica-gel is the most widely used adsorbent 
together with single or mixed solvents of low polarity. Although many spray reagents have 
been used, Fast blue B/BB gave the most sensitive detection. Generally, TLC is only used 
as a screening tool and it suffers from a lack of both sensitivity and specificity.
However, many improvements have been made to TLC systems with respect 
to detection and measurement of THC and its metabolites. A hexane extract of cannabis 
material was examined on silica gel G plates previously soaked in diethylamine. The 
toluene-developed plates were dried and sprayed with Fast blue 2B salt. Five spots 
corresponding to delta-9-THC, CBD, CBN, CBC and CBG, each with a different Rf value 
and a distinctive colour were observed/77^
In the procedure for detection of THCCOOH in urine described by Kanter et 
al.(34\  a silica-gel plate was used and developed first with acetone-chlorofonn-
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triethylamine (80:20:1) and then with petroleum ether-ether-acetic acid (50:50:1.5). The 
spray used was Fast blue B giving a detection limit in the 20-50ng/ml range.
Vinson et a l .^ 7) have developed a method based on fluorescence detection 
in which THC extracted from serum was derivatised with 2-p-chlorosulphonylphenyl-3- 
phenylindone prior to TLC. The developed plate was sprayed with an alkoxide to produce 
the fluorescent derivative and a detection limit of 0 .2 ng/ml was claimed.
Furthermore, it should be noted that screening procedures based on TLC are 
more specific for THCCOOH.^78' 81) Stated limits of THCCOOH detection from urine are 
25ng/ml using 1 0 ml(78), 20ng/ml using lO rn l^ ) ,  50ng/ml using 20ml^8^  and 2ng/ml 
using 2 ml of urine.(8 ^
2.3.3 High Pressure Liquid Chromatography (HPLC).
HPLC has been proposed for the determination of cannabinoids in biological 
fluids. The methods employed either normal- or reversed-phase separations with either 
Ultra-Violet (UV), Electro-Chemical (EC) or Fluorescence detection. Unfortunately, while 
UV detection lacks sensitivity and selectivity due to co-extracted interference, fluorescence 
detection requires the derivatization of THC. It seems that EC detection might be better 
since it is highly sensitive and it can eliminate the need for derivatization.
Kanter et al.(8^  reported that greater sensitivity for UV detection could be 
obtained by monitoring at shorter wavelengths, for example, the sensitivity at 215nm is 
thirty times that at 280nm. However, Valentine et a l / 83) reported that by reducing the 
wavelength from 274 to 209nm, the detection limit decreased from 1 0 0  to 2 ng/ml of delta- 
9-THC in human plasma.
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Analysis of cannabinoids in tissues which involved post-column 
derivatisation with Fast blue B salt and detection by UV at 490nm was reported by Borys 
and Karler^84). A detection limit of better than 50ng/ml was claimed. On the other hand, 
Abbott et al.(83) reported the detection at the low picogram range of delta-8 -THC and its 7- 
hydroxy metabolite using fluorescence detection of their dansyl derivatives.
An electrochemical detector at +1.1V was used by Nakahara et a l . ^ ^  in 
combination with a reversed-phase silica Cg column and a mobile phase of acetonitrile- 
methanol-0.02N sulphuric acid (35:15:50) at 1.8ml/min to detect delta-9-THCCOOH in 
urine and plasma. The detection limit obtained was under 0.5ng/ml (S/N >3).
HPLC has also been widely used in cleaning-up extracts or separating 
metabolites from unchanged cannabinoids in more sensitive techniques such as MS or RIA. 
Garrett and Hunt^8^  have investigated reversed and normal phase HPLC systems for 
separating delta-9-THC from its 1 1 -hydroxy metabolite and have used electron capture 
GLC as the detection system. A detection limit of 0.2ng/ml of plasma was claimed. 
Meanwhile, Williams et al.(87) have developed a specific and sensitive RIA method for 
delta-9-THC in plasma based on HPLC separation of cross-reacting metabolites. They 
have reported a detection limit of O.lng/ml.
2.3.4 Immunoassay.
Immunoassay techniques, either Radioimmunoassay (RIA) or Homogeneous 
Enzyme Multiplied Immunoassay Technique (EMIT), have the advantages of being more 
rapid, simpler to operate, requiring minimal sample size and not requiring complex 
equipment.
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RIA antibodies are raised by covalently linking the drug (hapten component) 
to a large molecule such as a protein to form the immunogen, which is then injected into 
animals (rabbit, cow, goat) to stimulate formation of antibodies. The binding site of the 
antibody accommodates the hapten with some ambiguity around the area which 
corresponds to the point of linkage in the immunogen.
The EMIT method is related to simple immunoassay techniques, and relies 
on the observation that certain enzymes can be inhibited by antihapten antibodies when the 
hapten is covalently bonded to the enzyme.
The major drawback of immunoassay methods is cross-reactivity, especially 
with non-specific antisera, which occurs between substances within the cannabinoid group, 
their metabolites and other drugs. This can reduce both the specificity and interassay 
precision and will definitely cause concern about the sole use of this technique. But, if 
employed with a subsequent confirmatory technique, such as HPLC or GC-MS, 
immunoassay is a valuable screening tool especially for batch samples. However, with 
specific antisera, it is possible to measure delta-9-THC directly.
Recently, Roche Diagnostics developed a latex agglutination immunoassay 
technique (ONTRAK). This technique provides the sensitivity of an immunoassay without 
the need for expensive equipment. It is based on the principles of latex agglutination- 
inhibition, where the test relies on the competition for binding to antibody between latex- 
drug conjugate and drug which may be present in the urine being tested.
Gross et a l / 88) produced an antiserum in goats following immunization 
with THC coupled to protein through an azo link to the aromatic ring and reported an assay 
limit of 25 to 50ng/ml. They also found that a cross-reactivity of 47% occurred with 11- 
hydroxy-delta-9-THC. Teale et a l / 89  ^ used a delta-9-THC-protein complex with THC
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attached by the phenol group to immunize sheep and have achieved a detection limit of 
7.5ng/ml in plasma and l.Ong/ml in urine for delta-9-THC.
Owens et al . ^ 9 ^ 9  presented a radioimmunoassay for delta-9-THC in plasma 
and whole or hemolyzed blood. An aliquot of the supernatant sample, extracted by 
methanol, was incubated with RIA buffer, radiolabelled delta-8 -THC and rabbit anti-THC 
serum. Solid-phase goat anti-rabbit immunoglobulins were added to separate bound from 
free THC and the supernatant fluid was later aspirated, after centrifugation. Radioactivity 
of the precipitate was counted in a gamma counter. The level of delta-9-THC in 0.1ml of 
sample was determined with a sensitivity of 1.5ng/ml in plasma and 3.0ng/ml in hemolyzed 
blood.
An HPLC/R1A method for the measurement of cannabinoids in plasma and 
urine was described by Moffat et a l / 9 ^  The method consisted of chromatographing a 
plasma extract or hydrolysed urine sample by HPLC and quantifying the eluted cross- 
reacting cannabinoids by RIA with non-selective antisera. Results obtained showed that the 
plasma levels of cannabinoids for volunteers who smoked lOmg THC were between 70 and 
6 ng/ml over the 2 -hour period examined.
2.3.5 Gas-Liquid Chromatography (GLC).
GLC methods offer more selectivity and in many cases, sensitivity, provided 
that a highly sensitive detection system such as electron capture or flame photometry is 
employed. But, it has been argued that GLC offers little advantage over TLC and it is less 
sensitive with flame-ionisation detection.(93^
Many stationary phases have been used for packed-column GLC separations 
which can separate all of the major cannabinoids and many of the minor ones, although the
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cannabinoid acids require derivatisation to prevent on-column decarboxylation. Moreover, 
glass packed-columns have been recommended in preference to stainless-steel ones which 
can cause up to 30% losses.
Novotny et a l . ( ^ )  demonstrated that because of the large number of 
cannabinoids present in many samples of cannabis material, capillary GLC can be used to 
advantage, where samples were concentrated on a pre-column and the resulting 
chromatograms could be used to "fingerprint" samples of marihuana.
Although good separations of the major neutral cannabinoids can be 
achieved on most phases, superior results can usually be obtained after derivatisation, 
particularly as TMS ethers.(9 3 ) The introduction of a derivatisation step results in 
improved peak shapes, reduced tailing and much higher sensitivities because sample losses 
through absorption are reduced. Derivatisation can also lead to large increases in 
sensitivity since it can be designed to suit specific sensitive detection systems. Moreover, 
TMS derivatives have the advantage of keeping the column and other parts of the system 
well silanised and thus nonpolar.
Fenimore et a l . ( ^  have compared the relative sensitivity of eight electron- 
capturing derivatives and obtained the best results for the heptafluorobutyryl ester (HFB), 
which was analysed on a dual-column chromatograph to minimise interference from co­
extracted material. The effluent was monitored by a flame ionization detector at the exit of 
the first column and only the effluent containing the THC peak was diverted into the 
second high-resolution capillary column for detection by electron capture. A detection 
limit of lOOpg/ml of blood was claimed.
Garrett and H u n t ( ^  used a packed column (OV-225) and 
pentafluorobenzoates in their GLC assay of delta-9- and delta-8 -THC. They claimed a 40
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to 125pg/ml detection limit with electron capture detection. Bachmann et a l . ^ ^  formed 
the HFB derivative prior to separation by TLC, and GLC detection using electron capture 
gave a detection limit of 8 pg for the pure THC and lng/m l from plasma.
As an alternative to electron capture detection, M c C a l l u m ( ^ )  has used 
flame photometric detection of the diethylphosphate derivative to give a detection limit of 
2ng/ml on a 3% OV-1 column. Later, McCallum and S h a w ^ )  extended the method to 
measure THC in brain, where lOng/g could be measured. In addition, Ritchie et a l.^ 2 )  
have determined delta-9-THC in whole blood that employs hexane extraction followed by 
identification using GC with nitrogen-phosphorous detection. Their method was sensitive 
to 2 ng/ml and linear for concentrations up to 1 2 0 ng/ml.
2.3.6 Gas Chromatography-Mass Spectrometry (GC-MS).
GC-MS represents the most sensitive and selective of all analytical 
techniques for cannabinoid analysis. It offers a very high degree of reliability, accuracy 
and precision, but the complexity and high cost of the instrument has restricted its use. The 
mass spectra of cannabinoids and in particular, their TMS derivatives are very 
characteristic due to the fragmentation pattern which is directed mainly by charge 
localisation on the pyran oxygen. However, silyl ethers having substituents capable of 
forming stable radicals following electron impact may produce additional ions representing 
loss of these radicals.
Detection limits of pure THC injected into a GC-MS instrument are in the 
upper picogram range^^^, but these can be improved by derivatisation of the phenol group, 
thus reducing polarity. A detection limit of 500fg has been obtained by derivatisation as 
the TMS ether.
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R o se n fe ld ^ ^ )  developed a GC-MS method for the simultaneous 
determination of delta-9-THC and 1 l-hydroxy-delta-9-THC (1 l-OH-delta-9-THC) in 
plasma using BSTFA:TMCS (9:1) as the derivatization reagent. It was noted that standard 
curves produced were linear from 0 -2 0 0 ng/ml of cannabinoid in plasma and recoveries 
obtained for delta-9-THC and 1 l-OH-delta-9-THC were 42% and 83% respectively. When 
the method was tested in an animal study, Rosenfeld observed that the maximum 
concentration of the metabolite obtained was less than lOng/ml and the metabolite seemed 
to be disappearing quite rapidly from the plasma.
The first GC-MS method based on selected ion monitoring for the 
measurement of delta-9-THC in plasma was published by Agurell et a l . ^ ^  in 1973. The 
sample was cleaned-up using Sephadex LH-20 and measured to lng/m l of plasma in the 
underivatised state using r , l ' - 2 H 2 -delta-9-THC as the internal standard. Other deuterated 
standards have been investigated but it was emphasized that deuterated standards prepared 
by a nonexchange method were superior to other standards.
Rosenthal et a l . ( ^  used hexane as the extracting solvent, rather than polar 
solvents, to reduce pre-GLC clean-up by reducing the amount of co-extracted lipid 
material. Reasonable extraction efficiencies and detection limits of 0.5ng/ml were 
achieved. Hexane was also used by Harvey et a l . ( ^ )  to extract delta-9-THC from plasma 
and tissues with a reported detection limit of 5pg/ml. This was achieved by measuring 
THC as its TMS derivative with a double-focussing MS tuned to a metastable ion rather 
than to the molecular or fragment ion, which greatly increased the selectivity and sensitivity 
of the instrument. Additional clean-up was not necessary.
The most sensitive GC-MS technique reported was the detection of 
pentafluorobenzoyl ester with electron-capture negative-ion chemical-ionization (N1CI)
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MS, where as little as lOfg could be detected / 1 GC-NIC1-MS techniques were also 
used by other workers.(65,71,72)
2.4 Conclusion.
Sample preparation techniques applied in the methods reviewed above 
employed either solvent or solid-phase extraction procedures. The former may lead to 
emulsion formation and a requirement for centrifugation leading to prolongation of analysis 
time, while the latter may provide rapid and clean sample preparation.
Many end-step analytical techniques have been utilised. TLC and 
RIA/EMIT lack specificity and are mainly used for screening purposes. HPLC and GLC 
have been widely used although they are less specific than GC-MS. However, the use of 
proper derivatives made them a powerful tool for confirmatory and quantitation purposes. 
On the other hand, GC-MS provides the most sensitive and specific instrumental technique, 
but its complexity and high cost have restricted its use.
In view of the capabilities of all the instruments reviewed above, HPLC and 
GC-MS were chosen for this study. Results with each technique will be compared and 
evaluated in order to establish the most reliable detection method for the analysis of 
cannabinoids in blood samples.
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CHAPTER 3. SAMPLE PREPARATION.
3.1 Introduction.
Cannabinoids can be extracted from plant, resin and biological materials. 
But, it is very difficult to extract them completely from biological fluids, and it is 
particularly challenging for the Forensic Scientist to extract them fully from blood samples.
Many solvents have been used, which include hexane and acetonitrile. 
C h r i s t o p h e r s e n ^ )  use(j hexane to extract THC from whole blood in his stability study and 
Bergman et a l .^ l )  have successfully extracted THC from whole blood samples with two 
15ml portions of hexane.
However, Foltz et a l.^ 4 ) reported that greater reproducibility and efficiency 
of cannabinoid extraction procedure can be obtained if the cannabinoids in blood are first 
separated from proteinaceous material using a polar water-miscible solvent such as 
acetonitrile. Their extraction procedure involved an addition of deuterium-labelled internal 
standard to hemolysed blood followed by 3N sulphuric acid and high purity acetonitrile, 
which permitted quantitation of THC and its metabolites at concentrations as low as 
0 .2 ng/ml of sample.
Whole or hemolysed blood samples, usually several days old, are the most 
common form of exhibit material received in most forensic Laboratories. Thus, the object
of this study was;
(a) to establish suitable methods for the analysis of cannabinoids in whole or
hemolysed blood samples from post-mortem cases, and
(b) to compare and evaluate suitable solvents and extraction techniques for the
sample preparation procedure.
3.2 Experimental.
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3.2.1 Materials.
Delta-9-THC and its trideuterated analog were obtained from Sigma 
Chemical Company while 1 l-nor-9-carboxy-delta-9-THC and its trideuterated analog were 
obtained from Alltech-Applied Science Laboratories. Delta-8 -THC was obtained from 
Macor, Jerusalem. Stock and working standards were prepared by appropriate dilutions 
with methanol at a concentration of 1 mg/ml and lug/m l respectively. The internal 
standards were the trideuterated analogs similarly prepared as above. All standards were 
stored in the freezer below 0°C.
All chemicals were A.C.S. grade and all solvents were HPLC grade obtained 
from BDH Laboratory, England. The derivatization reagent used was N ,0- 
bis(Trimethylsilyl)-trifluoroacetamide (BSTFA), which was obtained from Pierce & 
Warriner (UK) Ltd. Extrelut (Merck) was washed with dichloromethane and dried before 
use.
Glassware used was silanised by rinsing with a 5 %  (v/v) solution of 
dimethyldichlorosilane in toluene followed by methanol and then acetone and dried. This 
treatment cut down the loss of cannabinoids due to adsorption on glass surfaces.
3.2.2 Apparatus.
GC-MS was carried out with an integrated VG 70-250S/SE system equipped 
with Hewlett-Packard HP 5890 gas chromatograph and HP 7673 automatic sampler unit.
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The VG 70-250S/SE system has been developed from two separate units, the 
VG 70S/SE mass spectrometer and the VG 11-250 data system. The system utilizes all the 
facilities of the two separate units in a more compact form and is a complete mass 
spectrometer, control, data acquisition, data reduction and processing system.
The GC column was a Chrompack W COT Fused Silica Column (25m x 
0.32mm ID) with chemically bonded CP-SIL5CB coating material. It was connected to the 
mass spectrometer with the transfer line temperature held at 270°C. The GC temperature 
program was 200-300°C at 10°C/min. The injector temperature was 270°C and injections 
were done under splitless mode. Purified helium was used as the carrier gas at an average 
linear flow velocity of 60 cm/sec.
The MS was used in the electron impact (E l-*-) selected ion recording mode 
(SIR), programmed to detect ion peaks at m/z 371.24, 386.26, 473.25, 488.28, and for the 
trideuterated analogs, at m/z 389.28 and 491.29. Electron impact spectra were recorded at 
70eV ionization energy and a source temperature of 220°C. Photomultiplier was set at 
500V. Perfluorokerosene (PFK) was used as a mass marking calibrator for daily tuning of 
the instrument.
3.3 Evaluation of Extraction with Diatomaceous Earth.
3.3.1 Procedure.
A blood sample (0.5ml) was diluted with 0.5ml of deionized water and was 
spiked with 50ul (50ng) of the delta-8 -THC working standard. The sample was then 
poured into a glass column containing 1.5g of diatomaceous earth (Extrelut) and was 
allowed to equilibrate for at least 30 min. Extraction solvent (6.0ml) was added and the
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eluent was collected into a separate tube. The eluent was evaporated to dryness under a 
nitrogen stream at 60°C on a hot plate. The dried residue was reconstituted in 50ul of 
hexane and 50ul of d 3 -delta-9 -THC (IS) solution (50ng) was added, before storage in the 
freezer, until analysed by GC-MS.
Before analysis, the sample was again evaporated to dryness and 50ul of 
BSTFA was added to the residue. This derivatization process was carried out on a hot plate 
at 60°C for at least 30 min. A lul volume of the derivatized sample was injected into the 
GC-MS instrument.
The effects of the eluting solvent on the recoveries of THC were examined 
by using hexane, hexane-acetone ( 1 : 1 ), hexane-cyclohexane ( 1 : 1 ), hexane-dichloromethane 
(1:1), hexane-ethyl acetate (1:1), and hexane-isopropanol (1:1). Recoveries were measured 
by comparison of the ratio of delta-8 -THC to the IS in the extract with the corresponding 
ratio in an unextracted standard.
3.3.2 Results and Discussion.
Because cannabinoids are highly lipophilic and have a strong affinity to 
blood proteins, it was difficult to extract them completely from blood samples. Table 3.1 
gives the recoveries of delta-8 -THC obtained with various solvent combinations by extrelut 
extraction.
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Table 3.1 : Recoveries of delta-8-THC from blood samples 
by Extrelut extraction.
Solvents Total Recovery (%)
______________________________ Batch 1 Batch 2 Average
hexane 27.6 30.4 29.0
hexane-acetone ( 1 : 1  v/v) 2 0 . 0 22.4 2 1 . 2
hexane-cyclohexane ( 1 : 1  v/v) 10.5 14.7 1 2 . 6
hexane-dichloromethane ( 1 : 1  v/v) 9.5 7.4 8.5
hexane-ethyl acetate ( 1 : 1  v/v) 7.7 1 1 . 6 9.7
hexane-isopropanol ( 1 : 1  v/v) 17.7 26.3 2 2 . 0
acetonitrile (11=6 ) 68.3 ± 8 .2
From the above results, it was shown that recoveries were very poor. This 
was probably due to poor equilibration and mass transfer between the absorbed blood held 
in the matrix of the diatomaceous earth and the eluting solvent. Also, although all 
glassware had been previously silanised, losses due to adsorption on the walls of the vessel 
in which the solutions were prepared and used cannot be ignored.
Nakahara and C ook^7) explained that due to strong binding between 
cannabinoids and blood proteins, it is essential to precipitate the proteins in order to obtain 
good recoveries. Thus as recommended by Foltz et a l .( ^ ) ,  a polar water-miscible solvent, 
acetonitrile (CH 3 CN), was used for further extraction studies.
When CH 3 CN was used to elute the spiked delta-8 -THC and delta-9- 
THCCOOH, extracted as above using extrelut, recoveries obtained (n=6 ) were in the range 
of 58-82% and 23-55% respectively. Results were better than for the hexane-based
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systems, but the reproducibility was poor. This was due to clogging of some of the extrelut 
columns by the precipitated proteins, thus giving lower extraction yields.
3.4 Solvent Extraction.
3.4.1 Procedure.
A blood sample (0.5ml) was diluted with 0.5ml of deionized water and was 
spiked with 50ul (50ng) of delta-8 -THC working standard solution. CH 3 CN (5.0ml) was 
added, followed by vortexing for 2 min. The solution was centrifuged for 10 min at 4000 
rpm. The supernatant solution was collected and the process was repeated with 2ml of 
CH 3 CN. The combined supernatant was evaporated to dryness under a nitrogen stream at 
60°C. The residue was reconstituted in 50ul of n-hexane and 50ul (50ng) of the deuterated 
analog internal standard solution was added. The sample was stored in the freezer until 
analysed. Derivatization and injection conditions were similar to those described earlier 
(Para. 3.3.1).
3.4.2 Results and Discussion.
The recovery for delta-8 -THC was found to be 80.7%. This higher recovery 
obtained is due to the liquid-phase extraction which has been effectively employed for the 
determination of THC and its metabolites in minute volumes of blood samples ranging 
from clear serum to hemolyzed blood.(45,55,59-64,65-69) Acetonitrile deproteinization 
breaks the lipophilic bonds between the blood proteins and the cannabinoids, leaving the 
cannabinoids freely dissolved within the supernatant layer. Moreover, vortexing facilitates 
the extraction/equilibration process while centrifugation separates the extracted
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cannabinoids from the precipitated blood sample. These factors account for a higher 
reproducibility in the extraction yields that were obtained.
3.5 Comparison of Diatomaceous Earth and Solvent Extraction.
3.5.1 Procedure.
A comparison between solid-phase and solvent extraction methods was done 
simultaneously using blood spiked with 50ng of delta-9-THC and delta-9-THCCOOH. 
Extraction procedure was as described earlier (Para. 3.3.1 & 3.4.1), with acetonitrile as the 
extraction reagent.
3.5.2 Results and Discussion.
The extrelut extraction procedure gave lower recoveries of 70.35% and 
43.88% for delta-9-THC and delta-9-THCCOOH, respectively. Better results were 
obtained with the solvent extraction procedure despite the large variation of values obtained 
for delta-9-THCCOOH. Full recovery results are listed in Table 3.2.
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Table 3.2 : Recoveries of THC and THCCOOH by two 
extraction procedures (n=4).
Analyte Extrelut
(%)
Solvent
(%)
THC
sample : 1 75.19 79.80
2 70.81 86.17
3 69.62 80.80
4 65.80 81,49
average 70:36 82.07
THCCOOH
sample : 1 55.09 111.21
2 24.91 92.82
3 41.01 55.70
4 14*51 71.22
average 43,88 82.74
Large variations in extraction efficiency did occur occasionally in blood 
analysis since cannabinoids and their deuterated analogs were tightly bound to the proteins. 
The extraction ratio between the two cannabinoids (THC/THCCOOH) was variable and 
ranged from 0.73 to 1.28. Thus, homogeneity of spiked samples is important for extraction 
efficiency. Moreover, since the samples were run in two batches on two different days, the 
variation of results obtained from those two days has contributed to the high values. The 
within-day and between-day variances were not studied in more detail.
3.6 Effect of pH on Recovery.
3.6.1 Procedure.
Further analyses were conducted to find out whether pH has any effect on 
the recoveries by solvent extraction. Acetate buffer of pH 5.0 and phosphate buffer of pH
7.4 were prepared and added to the blood samples separately, before the additions of
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standards. Blood samples wirh deionized water added were also prepared for comparison. 
Extractions were carried out similarly to those described in Para. 3.4.1.
3.6.2 Results and Discussion.
Nakahara and S e k in e ^ ^ ) , in their extraction analysis using disposable 
ODS-Minicolumns, reported that recoveries of drugs from biological samples were affected 
by the pH of the solution. They found that cannabinoids were absorbed maximally at pH 
5.0 and minimally at pH 8.0. However, results obtained in the present study (Table 3.3) 
showed the opposite, with pH 5.0 having the lowest recovery with a large CV while 
deionized water gave better results.
Table 3.3 : Comparison of THC and THCCOOH recoveries by 
pH of solutions (n=5).
Analyte pH 5.0
( %)
Assavs
water
( %)
pH 7.4
( %)
THC
mean recovery 80.13 83.23 82.45
std. deviation 14.01 3.57 4.15
CV 17.48 4.29 5.03
THCCOOH
mean recovery 74.18 86.90 115.98
std. deviation 19.06 17.31 39.67
CV 25.69 19.92 34.20
Erratic results were obtained for THCCOOH at pH 7.4 with recoveries 
above 100%. However, it seemed that the binding between cannabinoids and blood 
proteins was not affected markedly by the pH of the solution. This can also be confirmed 
when comparing recovery results between Tables 3.2 and 3.3.
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3.7 Preparation of Calibration Curves.
3.7.1 Procedure.
Calibration curves for THC and THCCOOH were determined as peak area 
ratios of drug/lS plotted against their corresponding spiked concentrations in blood. Since 
THC persists in blood of users at the low nanogramme level, standards were spiked in the 
range 0-80ng/ml and assayed. A solvent extraction procedure was followed as described 
before (Para. 3.4.1).
3.7.2 Results and Discussion.
The plots for THC and THCCOOH (Figure 3.1) were linear within the 0- 
80ng/ml range with linear regression correlation coefficient values of 0.9997 and 0.9939 
respectively. This linear relationship of the solvent extraction procedure provides 
confidence that the method can be utilised as a preliminary step for further analysis.
3.8 Clean-Up Procedure.
The Bond Elut Certify II (Analytichem Int'l) extraction columns was 
specifically designed for the extraction of THC and its metabolite from biological samples. 
It provides two extracts containing THC and THCCOOH, respectively. The clean-up 
procedure as recommended by the manufacturer, with slight modifications, is as follows;
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a) Solutions required.
(1) 1.0M HC1 (500 ml).
(2) 0.1M Sodium acetate buffer, pH 7.0 with 5% methanol.
In 450 ml deionized water was dissolved 6 .8 g of sodium acetate (MW 
136.08). The pH was adjusted to 7.0 (+/-0.1) with 1.0M HC1 while stirring. 
The volume was brought up to 500ml with deionized water and was mixed 
well. 25ml of the buffer was removed and discarded, while approximately 
25ml of MeOH was added to bring back the total volume to 500ml. The 
buffer was mixed well and stored at room temperature.
(3) MeOH-H20  (1:1) (200 ml).
(4) Hexane-ethyl acetate (95:5) (100 ml).
(5) Hexane-ethyl acetate (75:25) with 1% acetic acid solution (100 ml).
b) Specimen Preparation.
Solvent extraction and deproteinization of spiked blood samples were done 
as before. However, instead of evaporating the supernatant to dryness, the samples were 
evaporated down to approximately 1ml under a slow stream of nitrogen at 30°C. To the 
samples were added 4.0ml of the prepared buffer.
c) Bond Elut Certify II Preparation.
The column was placed into a Vac Elut Box, plugging any unused ports. To 
the column was added 2.0ml MeOH and 2.0ml buffer sequentially, making sure that the 
vacuum was turned off as soon as the solvent/buffer reached the top of the sorbent bed to 
prevent column drying.
d) Specimen Application.
The specimen was poured into the column reservoir. The brass Vac Elut 
flow valve was opened in order to reduce the vacuum so that the specimen would be drawn
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down slowly through the column. It should take at least two minutes to pass the specimen 
through the column.
e) Column Rinse.
Buffer (1.0ml) was added and passed through. The column was then dried 
under full vacuum (15 in. Hg) for five minutes.
f) Elution of Free Cannabinoids.
A labelled vial was placed into the Vac Elut which, contained a rack, and the 
tip of the Vac Elut delivery needles was wiped clean. 2.0ml of hexane-ethyl acetate (95:5) 
were passed through the column slowly, taking at least two minutes. The vial containing 
the eluant was removed.
g) Column Rinse.
The column was rinsed with 5.0ml MeOH-H20  (1:1) and was then dried 
under full vacuum for five minutes.
h) Elution of Acidic Cannabinoid.
Another labelled vial was placed into a rack in the Vac Elut. The delivery 
needle was wiped clean and 2.0ml of hexane-ethyl acetate (75:25) with 1% acetic acid was 
added. The eluant was passed through the column slowly and was collected in the vial.
i) Sample Concentration and Injection.
Eluants collected in both vials were evaporated to dryness under a slow 
stream of nitrogen at 30°C and were then reconstituted into either mobile phase or 
derivatization reagent for HPLC or GC-MS analysis respectively.
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3.9 Conclusion.
Extraction using hexane and combinations of hexane with other organic 
solvents gave low recoveries. Acetonitrile proved to be a better extraction solvent since it 
can also deproteinize the blood sample, freeing the cannabinoids from the precipitated 
blood proteins.
The precipitates formed caused clogging of the extrelut columns. This 
resulted in variable extraction yields. However, the problem could be eliminated by 
employing a solvent extraction procedure, where the centrifugation step divides the 
cannabinoids in the supernatant acetonitrile solution from the precipitated blood sample. 
GC-MS analyses showed that more acceptable recoveries were obtained and the procedure 
was linear from 0 to 80ng/ml of THC and THCCOOH in blood samples. In addition, the 
overall recoveries of THC, CBD, CBN and THCCOOH after extraction and clean-up 
procedures were found to be above 85% (Table 4.6). Figure 3.2 shows a flow diagram for 
the recommended procedure for the solvent extraction of cannabinoids from blood samples.
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Figure 3.2 : Recomended Solvent Extraction Procedure.
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C H A PT ER  4. H PLC  ANALYSTS.
4.1 Introduction.
High pressure or high performance liquid chromatography (HPLC) has been 
developed and used since the late 1960's. It is a complementary technique to gas 
chromatography (GC) in that HPLC can be used to analyse compounds which are thermally 
labile. HPLC technique relies on interactions (adsorption, partition, ion exchange and 
molecular exclusion) between the mobile and stationary phases to cause differences in the 
migration rates of the components of substances analysed, thus achieving a separation.
The range of appropriate solvents for the mobile phase is extensive and the 
selection depends on many factors including the type of sample analysed and the detection 
system available. The strength and polarity of the solvent used will determine the type of 
chromatography involved. In adsorption and normal-phase liquid chromatography, the 
solvent strength increases with polarity while in a reversed-phase system, the solvent 
strength decreases with increasing polarity. The latter is particularly suitable for the 
separation of a homologous series of compounds with the same functional group. 0 ^ 3 )
A variety of detectors is available for HPLC. These include the UV-visible 
spectrometer, the fluorescence and the electro-chemical detectors which can detect 
compounds that absorp in the UV-visible wavelengths, that can fluoresce and that can be 
readily oxidised or reduced within the voltage range of the electrodes, respectively. Other 
principles like the refractive index, radiochemical, atomic absorption spectrometry and the 
mass spectrometry have also been utilised as HPLC detectors.
Electrochemical detection is dependent upon some electroactivity of the 
solute in the mobile phase through oxidation or reduction, or the ability to act as a
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conductor of an electrical charge. The electrochemical (coulometric) detector used is based 
on current measurements at fixed electrodes. Its principle is the application of a potential 
difference across two electrodes resulting in an electrochemical reaction at the surface of 
the working electrode. The electrons produced are atttacted to the working electrode and 
the resultant current flow is measured, which is directly proportional to the number of 
molecules oxidised.
Generally, the sensitivity of electrochemical detection is good and is capable 
of detecting picograms of many electroactive species.(104) Moreover, it is also considered 
to be selective since only electroactive species will provide a response, and the selectivity 
can be varied by altering voltages for oxidation-reduction reactions. For example, easily 
oxidizable solutes could be selectively detected in the presence of solutes that are more 
difficult to oxidize by maintaining the potential below that necessary for oxidation of the 
latter but high enough to cause a reaction with the former.
At present, most HPLC analyses are carried out by direct means without the 
need to derivatise compounds. However, in some instances, direct analyses are not possible 
at the desired level of sensitivity. Thus, chemical derivatisation can be used to increase the 
sensitivity and selectivity of a detector, particularly in absorbance and fluorescence 
detection.
4.2 Materials.
4.2.1 Chemicals and Analytical Standards.
All solvents were of HPLC grade obtained from BDH Laboratory, England 
while all chemicals were Analar grade materials.
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Four analytical standards were used in this study. Three of them, delta-9- 
THC, cannabinol and cannabidiol were obtained from Sigma Chemical Co., while the other 
, delta-9-THCCOOH was obtained from Alltech-Applied Science. The internal standards 
used, n-octyl p-hydroxybenzoate and phenylbutazone, were obtained from Lancaster 
Synthesis and Ciba-Geigy Pharmaceuticals, respectively. Stock and working standards 
were prepared in methanol by appropriate dilutions to give a concentration of 1 0 0  and 
lug/m l. Internal standards were also prepared the same way to give concentrations of 
lOug/ml and 50ug/ml respectively.
4.2.2 Apparatus.
The system consisted of an LKB Bromma 2150 HPLC pump, a Rheodyne 
injection valve with a 20ul loop and two stainless steel columns from HPLC Technology, 
connected to each other with a 2cm stainless steel tubing. Sizes of the columns were 5cm 
by 4.6mm (pre-column) and 25cm by 4.6mm (analytical column) internal diameter, both 
packed with Lichrosorb RP 8  (5 micron).
The detectors, both connected in series with the column, were a 
programmable Ultra-Violet multi wavelength detector (Waters model 490-MS) and an 
amperometric detector model LC-4B from Bioanalytical Systems (BAS, West Lafayette, 
USA). The electrochemical detector consists of a glassy carbon working and a silver/silver 
chloride reference electrodes. Glassy carbon electrodes were used because they showed 
much promise for detecting electrochemically oxidizable compounds with high current 
y i e l d . B o t h  detector responses were recorded on a quadruple pen INSEIS chart 
recorder.
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4.3 Selection of Mobile Phase.
4.3.1 Introduction.
Four mobile phases were evaluated, all containing the same components but 
at different ratios. In three of the mobile phases, the percent of C H 3 CN was changed 
against a constant ratio of methanol-0.02N sulphuric acid (15:50), in order to find the 
optimal conditions for the separation of the cannabinoids. This determined the capacity 
factors (k1) which were measured as a function of the organic modifier content. The fourth 
mobile phase had a higher methanol content.
All mobile phases were degassed by purging with helium gas for 10 min 
before use. The four mobile phases, evaluated at a flow rate of 1.5ml/min, were;
(1) CH 3 CN-MeOH-0.02N H 2 S 0 4  (15:15:50, v:v:v)
(2) CH 3 CN-MeOH-0.02N H 2 S 0 4  (35:15:50, v:v:v)
(3) CH 3 CN-MeOH-0.02N H 2 S 0 4  (65:15:50, v:v:v)
(4) CH 3 CN-MeOH-0.02N H 2 S 0 4  (16:7:6, v:v:v)
4.3.2 Procedure.
Blood (0.5ml) was spiked with lOOul of delta-9-THC, CBD, CBN and delta-
9-THCCOOH. Extraction and clean-up procedures were followed as recommended earlier 
(Para. 3.6). Both extracts of the sample from the clean-up procedure were evaporated to 
dryness under a nitrogen stream at 60°C and were later reconstituted into 30ul of mobile 
phase. A 25ul sample was injected into the HPLC system.
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4.3.3 Results and Discussion.
All four mobile phases were examined with the standards at a flow rate of 
1.5ml/min (Figure 4.1). They all eluted the cannabinoids with capacity factors (k1) of THC 
ranging from 1.57 (with mobile phase 4) to 13.36 (with mobile phase 3). Table 4.1 gives 
the complete list.
Table 4.1: Comparison of k' values for THC, CBD, CBN,
THCCOOH and IS with different mobile phases.
Mobile Capacity Factors (k1) of Analyte
Phase THC CBD CBN THCCOOH
4 1.57 1 . 0 0 1.36 0.64
1 2.80 2 . 2 0 2.60 0.80
2 8 . 8 6 6 . 8 6 7.86 3.14
3 13.36 8.64 11.71 4.43
From the above list, mobile phases 2 and 3 gave the desired retention 
volume of eluted analytes with good separations. However, it was observed that sharper 
peaks were obtained with mobile phase 3 due to its higher CH 3 CN content. Thus, mobile 
phase 3 was used for the HPLC system.
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Figure 4.1 : Cannabinoid Chromatographs by Different Mobile Phases. 
( 1 ) THCCOOH (2) CBD (3) CBN (4) THC.
4.4 Detector Optimisation.
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4.4.1 Selection of UV Wavelengths.
4.4.1.1 Procedure.
The absorbance maxima in the UV spectra of the four standards used were 
obtained by running the standards on a Hewlett-Packard UV diode array spectrophotometer 
model HP 1845A. A solution containing lOOul of the working standard in 5.0ml of mobile 
phase was used (Figures 4.2a - d).
4.4.1.2 Results and Discussion.
All cannabinoids analysed showed maximum absorbances in the range of 
200-280nm (Table 4.2). Since Kanter et a l . ^ ^  and Valentine et a l . ( ^ )  have reported that 
greater sensitivity for UV detection could be obtained by monitoring at shorter 
wavelengths, the THC maximum absorbance at 212nm was chosen for the UV detector. 
Besides that, 220nm was also used for comparison since the wavelength has been 
extensively used by r e s e a rc h e rs .^ >66-7)
Table 4.2 : UV absorbance wavelengths for THC, CBD, CBN, and THCCOOH.
Analyte Maximum UV Absorbance Wavelengths 
(decending order)
THC 212,280.
CBD 202 ,206 ,212 ,226 .
CBN 220, 224, 228, 286, 204.
THCCOOH 258,230, 234 ,212 ,218 .
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Figure 4.2a : UV Spectra of THC in M obile Phase 3.
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Figure 4.2b : UV Spectra of CBD in M obile Phase 3.
A
B
SO
R
B
A
N
C
E 
A
B
SO
R
B
A
N
C
E
- 5 4 -
4
2
0
8
6
4
2
0
2
3  o o1 9 0 2 6 02 2 0
W AVELENGTH (nm)
Figure 4.2c : UV Spectra of CBN in Mobile Phase 3.
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Figure 4.2d : UV Spectra of THCCOOH in Mobile Phase 3.
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4.4.2 Variation of ECD Potential.
4.4.2.1 Procedure.
Electrochemical detection of standards was evaluated at an applied potential 
o f +1.10 Volts vs the reference electrode. However, the potential applied to the working 
electrode was varied in order to observe its effects on sensitivity since electrode responses 
vary with the applied potential. A full cyclic voltamogram was not carried out because the 
required equipment was not available.
4.4.2.2 Results and Discussion.
At an applied potential of + 1.10V, all cannabinoid peaks were at a maximum 
height. When the potential was lowered to +1.00V, no peaks were observed for THC and 
THCCOOH while those for CBD and CBN were reduced significantly. Increasing the 
potential from +1.10V to +1.20V only results in decreasing the sensitivity. Hence, an 
applied potential of +1.10V was chosen for the electro-chemical detector because it gave 
high response with low background noise. Full results are listed in Table 4.3.
Table 4.3 : Effect of Potential Variation on Sensitivity of Standards.
Applied Potential 
(V) THC
Peak Height (cm)
CBD CBN THCCOOH
1 . 0 0 - 0 . 2 0 0.30
1 . 1 0 1.50 2.60 2.70 7.90
1.15 0.65 1 . 2 0 1.10 7.70
1 . 2 0 0.25 0.50 0.45 3.25
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4.4.3 Detection Limits (Sensitivity).
4.4.3 . 1  Procedure.
With UV and EC detectors set at 212nm (AUFS 0.01), 220nm (AUFS 0.01) 
and + 1.10V (range 5nA) respectively, the detection limits (signal-to-noise ratio > 3) of the 
standards were determined. Standard mixtures of concentration lOOng/ml were extracted 
and analysed on the HPLC system. The concentration was subsequently decreased by a 
factor of two for further injections.
4.4.3.2 Results and Discussion.
Results showed that THCCOOH gave the lowest possible detection limits 
for both detectors while CBN had the poorest sensitivity (Table 4.4). As expected, electro­
chemical detection was more sensitive, with detection limits ranging from 1 .0 -2 .5 ng/ml of 
cannabinoids while the detection limits with the UV detector ranged from 10-100ng/ml and
10-60ng/ml of cannabinoids at wavelengths 2 1 2 nm and 2 2 0 nm respectively.
Table 4.4 : Detection Limits of Cannabinoids by UV and EC Detectors.
Analyte Limits of Detection (ng/mll 
UV 212nm UV 220nm E C + 1 .1 V
THC 2 0 2 0 2.5
CBD 2 0 2 0 1 . 0
CBN 1 0 0 60 2.5
THCCOOH 1 0 1 0 1 . 0
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4.5 Selection of Internal Standards.
4.5.1 Procedure.
The internal standard (IS), n-octyl p-hydroxybenzoate, as recommended by 
N a k a h a ra ( ^ )  was used. It was found that the IS was separated by the Bond Elut Certify 
II column into the THC portion. This left the acidic metabolite without any IS.
Analgesic drugs and chemicals with either hydroxyl or carboxyl functional 
groups and also those with long carbon chains were tested as internal standards for 
THCCOOH analysis. Ten test compounds were prepared with appropriate dilutions to give 
concentrations of lOug/ml in methanol. These were injected into the HPLC system in order 
to select the best possible IS for the THCCOOH extract.
4.5.2 Results and Discussion.
It can be seen that UV detection gave a good response for all of the possible 
IS examined. However, for EC detection, only six out of the ten tested were oxidized at the 
electrode surface, thus giving good responses (Table 4.5). When the k' values of these six 
IS were compared with chromatograms of the acidic extracts of blank blood, 
phenylbutazone was observed to be the best choice since it was eluted within 6.45 min, 
clear of the solvent front and in a range where not many interfering peaks occurred. Hence, 
phenylbutazone was chosen as the IS for the acidic cannabinoid assays.
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Table 4.5 : Retention Times and Responses of some Analgesic Drugs and 
Chemicals in Mobile Phase 3.
Drug/Chemical 
(obtained from)
Retention Time 
(min)
Method of Detection 
UV UV ECD
212nm 220nm +1.10V
3,3-Naphthalene 
dicarboxylic acid 
(Aldrich Chem. Co.)
Aspirin 
(Hopkin &
Williams Ltd.)
Salicylic acid 
(unknown)
3.00
3.30
3.45
Naproxen 4.35
(Syntex Pharm. Ltd.)
Ketoprofen 4.35
(May & Baker Ltd.)
Anthracenecarboxylic 4.65
acid
(Aldrich)
Fenbufen 4.80
(Lederle Lab.)
Oxyphenbutazone 5.55
(Ciba-Geigy Pharm.)
Ibuprofen 5.85
(Boots Co.Ltd.)
Phenylbutazone 6.45
(Ciba-Geigy)
* *
* *
* *
* *
* *
* *
**
* *
* *
* *
**
* *
* *
* *
* *
* *
* *
ND
ND
* *
ND
**
** = good response 
* = poor response 
ND = not detected
4.6 Recovery and Calibration Curves.
4.6.1 Procedure.
Standards of concentration lOOng/ml were analyzed according to the 
extraction and clean-up procedures described earlier (Para 3.6). Before extraction, all
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samples were also spiked with 50ul of internal standards (n-octyl p-hydroxybenzoate, 
lOug/ml and phenylbutazone, 50ug/ml). Analytical recoveries were calculated by 
comparing peak height ratios of the extracted standards to the non-extracted standards.
To determine the calibration curves for cannabinoids, spiked blood samples 
of concentration 0, 5, 25, 50, 75, 100, 150, and 200ng/ml were prepared. The detectors 
were set at UV AUFS of 0.08 and ECD range of lOOnA. These values were lowered to 
0.03 and 20nA, respectively, as the cannabinoids concentrations decreases. Peak height 
ratios of cannabinoids/IS were plotted against the concentration.
4.6.2 Results and Discussion.
The high recoveries obtained indicate that most of the cannabinoids were 
recovered during the extraction and clean-up procedures (Table 4.6). All recoveries were 
obtained without many co-extracted interferences, especially the THC extract. Recoveries 
of delta-9-THC and delta-9-THCCOOH did not vary greatly from those results obtained for 
solvent extraction studies (Table 9). In fact, UV and ECD detection for this HPLC system 
gave higher calculated recoveries than GC-MS under electron impact mode.
The calibration plots (Figure 4.3a to 4.3c) showed that THC, CBD and CBN 
were linear from 0-200ng/ml. At UV wavelengths 212nm, 220nm and ECD working 
potential of +1.10V, linear regression analysis indicated that the correlation coefficients for 
THC were 0.9995, 0.9962 and 0.9989; CBD were 0.9983, 0.9979 and 0.9990; and CBN 
were 0.9868, 0.9909 and 0.9965 respectively.
On the other hand, only electrochemical detection gave a linear calibration 
curve for THCCOOH from 0-200ng/ml. UV detection at both wavelengths was linear from
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Table 4.6 : Recoveries of Cannabinoids (n=3) Determined After Extraction
and Ciean-Up Procedures.
Analyte UV/212nm
Recoveries ( %)  
UV/220nm EC/+1.1V
THC
sample : 1 92.30 92.30 94.60
2 85.71 80.00 87.88
3 95:35 94.44 97.62
average 91.12 M-91 93.36
CBD
sample : 1 102.30 104.80 1 0 2 . 0 0
2 93.75 87.50 1 0 0 . 0 0
3 84.62 88.24 &L2Z
average 93:56 93.51 94,66
CBN
sample : 1 92.30 93.30 105.00
2 83.33 83.33 94.83
3 94,74 90.0Q 96,30
average 9 0 . 1 2 8 8 . 8 8 98.71
THCCOOH
sample : 1 85.48 83.33 78.20
2 98.44 98.00 94.44
3 90.14 9Q J4 94.74
average 91-35 90.69 89,13
0-100ng/ml. But, from 100-200ng/ml, it gave a concave isotherm which is rarely observed 
in liquid chromatography. These non-ideal isotherms with increasing quantity of sample 
injected, usually result in a slight change of the retention times of the peaks. 1 ^ 4 )  
However, these slight changes were not observed.
Poor extraction yields for the internal standard which gave rise to higher 
ratios might be one of the answers for the results obtained at concentrations 1 0 0 -2 0 0 ng/ml. 
Other reasons might be due to interference from co-extracted materials or even possibly 
due to wrongly prepared spiked samples. Therefore, UV detection for THCCOOH at 
wavelengths 2 1 2  and 2 2 0 nm is considered to be linear only from 0 - 1 0 0 ng/ml with 
correlation coefficients and slopes of 0.9972, 0.0156 and 0.9746, 0.0150 respectively.
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4.7 Case Sample Analysis.
4.7.1 Sample Collection.
The Toxicology section of the Department of Forensic Medicine & Science 
at Glasgow University undertakes analyses of drugs in samples of blood and urine received 
from pathologists employed by the Crown Office, the police, clinicians and solicitors. 
These samples can be divided into cases such as homicides, suicides, and road traffic 
accidents.
A total of eight post-mortem blood samples were received for this study. 
The age distribution ranged from 16 to 71, and five of the samples were from male victims. 
Cases involved were deaths either due to road traffic accidents, drug overdoses or 
inhalation of vomitus. All samples had given positive results with the routine R1A screen.
4.7.2 Procedure.
Internal standards (50ul of working standard solution; 50ng) were added to 
0.5ml of the case blood samples. Deionised water was added to make the volume up to 
1.5ml. All extraction and clean-up procedures were conducted exactly as recommended 
(Para 3.6), together with a blood sample spiked with standards of concentration lOOng/ml 
and a blank sample spiked with internal standards. The extracts were analysed by HPLC 
using the instrument described earlier, with solvent system 3 (Para. 4.3.1).
4.7.3 Results and Discussion.
It is to be expected that most samples will show negative results for the 
parent compound, THC and positive results for the metabolite. When smoked, THC
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reaches a maximum blood level within a few minutes and then falls rapidly to a few ng/ml 
of blood. Only 3% of THC present in the blood is in the free state, the remaining 97% is 
bound mainly to proteins, with about 9% bound to blood cells, but THCCOOH is even 
more strongly bound with values up to 99% have been reported. (1^6) workers in this 
field report that a percentage of samples showing positive in the initial immunoassay screen 
subsequently show negative in the confirmatory analysis for THC and THCCOOH, 
presumably because of the presence of other cross-reacting substances which are not 
detected in the confirmatory test.
Results obtained for the eight samples (Table 4.7) showed that THC and 
CBN were absent for all of the test samples. Electro-chemical detection of CBD gave five 
positives whereas negative results were obtained with UV detection. These were 
unexpected and very surprising because CBD is usually the major cannabinoid found in 
fiber type cannabis plant. However, elevated values due to interference cannot be ignored 
since the blank too shows a peak at the same retention time as CBD, which was not present 
during earlier studies. Figures 4.4a to 4.4c shows the HPLC chromatographs of 
cannabinoid sample detected by UV and ECD..
Detection of THCCOOH by both detectors showed positive results for all 
test samples. However, some of them were below the safe detection limits of the method 
and had to be considered as negative. It was also observed that results obtained by UV 
detection at 220nm gave higher values than at wavelength 212nm, thus showing that the 
former wavelength is more sensitive than the latter. But, when comparing results obtained 
by UV detection at 220nm with those from ECD, it was observed that neither UV or ECD 
proved to be reliable in giving a true picture of the metabolite level in blood. Thus, half of 
the samples gave a higher result for ECD compared to UV at 220nm, whereas the other half 
were lower than UV at 220nm.
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(a) Unextracted Standards 
AUFS 0.05
(b) Extracted THC Fractions: 
(i) Blank with IS 
AUFS 0.03
(ii) Spiked Sample lOOng/ml 
AUFS 0.07
(iii) Case Sample 
AUFS 0.12
(c) Extracted THCCOOH Fractions
(i) Blank with IS 
AUFS 0.03
(ii) Spiked Sample lOOng/ml 
AUFS 0.06
2(iii) Case Sample 
AUFS 0.15 /
“1---
1236 1*8
1
30
Retention Time (min)
Figure 4.4a : Chromatographs of Cannabinoid Samples Detected by UV 212nm.
(1) phenylbutazone (2) THCCOOH (3) n-octyl p-hydroxy benzoate
(4) CBD (5) CBN (6) THC.
- 6 8 -
(a) Unextracted Standards
AUFS 0.05
M__A
(b) Extracted THC Fractions:
(i) Blank with IS 
AUFS 0.04
_________
(ii) Spiked Sample lOOng/ml
AUFS 0.07
(iii) Case Sample 
AUFS 0.15
L /
(c) Extracted THCCOOH Fractions:
(i) Blank with IS 
AUFS 0.03
2 1(ii) Spiked Sample lOOng/ml 
AUFS 0.06
V K(iii) Case Sample 
AUFS 0.09
2 1
"I--
12
_ r
6~L8
Retention Time (min)
Figure 4.4b : Chromatographs of Cannabinoid Samples Detected by UV 220nm.
(1) phenylbutazone (2) THCCOOH (3) n-octyl p-hydroxy benzoate
(4) CBD (5) CBN (6) THC.
(b) E xtracted  '111C Fractions
(i) Blank with IS 
Range 20nA
(ii) Spiked Sample lOOng/ml 
Range lOOnA
(iii) Case Sample 
Range 20nA
(iii) Case Sample 
Range 20nA
(c) Extracted THCCOOH Fractions
(i) Blank with IS 
Range 20nA
(ii) Spiked Sample lOOng/ml 
Range 5QnA
36 30 zb 18  12
Retention Time (min)
Figure 4.4c : Chromatographs o f Cannabinoid Samples Detected by ECD + 1  1 ()V
(1) phenylbutazone (2) THCCOOH (3) n-octyl p-hydroxy benzoate
(4) CBD (5) CBN (6) THC. yuroxy oenzoate
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If HPLC is the only method available for the analysis of cannabinoids in 
blood and urine, the use of more than one type of detector is clearly advisable to improve 
the degree of reliability of identification and quantitation of the target analytes, especially 
when dealing with an inhomogeneous complex sample matrix such as autopsy blood.
Since the sensitivity of ECD detection for the analysis of cannabinoids is 
over 400 times greater than that of UV at 220nm,(107) it is assumed that those results by 
UV at 220nm which are higher than ECD are due to interferences from co-extracted 
materials. These interferences differ from sample to sample reflecting different dietary 
intake of each individual. In addition, the possibility of co-extracted materials that might 
resemble cannnabinoids by having a phenolic group, which may also undergo oxidation at 
the electrode surface, thus producing interferences, cannot be ignored.
4.8 Conclusion.
Use of UV and ECD detectors in the described HPLC system produced 
linear calibration curves from 0-100ng/ml. Total delta-9-THCCOOH levels in test blood 
samples have been quite low (l-24ng/ml), whereas delta-9-THC and CBN were not 
detected and only ECD gave positive results for CBD. UV at 220nm proved to be more 
sensitive than at 212nm, but when compared to ECD, neither of them showed to be better 
than the other.
The THC extracts gave chromatograms clear of interference except for ECD 
where an interference peak was observed at the same retention time as THC. The 
metabolite portion contained many nearby interferences. Thus, further work is necessary to 
improve the clean-up procedure before this HPLC method can be used for routine analysis.
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CHAPTER 5. GC-MS ANALYSIS.
5.1 General Introduction.
Mass spectrometry is the basis of the most specific and sensitive detector for
gas chromatography. It has been particularly useful for bio-analysis. Recently, HPLC 
coupled with an MS detector has also been developed for analysis of biological samples.
compounds of widely varying volatility, (2 ) to ionise and produce fragment ions from 
molecules in the gas phase, and (3) to separate fragmented ions according to their mass-to- 
charge ratios (m/z), detect and record them in a form of a mass spectrum, a graph of mass- 
to-charge ratios of the fragments plotted against relative abundance. The basic components 
of a double-focussing mass spectrometer are shown in Figure 5.1.
The technique relies upon three basic functions. These are (1) to vapourise
Free Region
1st Field-
a 2nd Field- 
Free Region
Mi" Y. i,-if
: , ! ; i . . . .
h e g l o n
Electrostatic
Sector
Magnetic
Sector
Collector
Figure 5.1 : Components of a Double-Focussing Mass Spectrometer.
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Sample inlet systems allow the introduction of samples - solids, volatile 
liquids or gases, into the ionisation source. The instrument used in the present study was 
equipped with three inlets including a direct capillary (GC) inlet and a septum inlet. The 
latter was used regularly for the introduction of volatile liquid samples such as 
perfluorokerosene (PFK), used to calibrate the mass range of the spectrometer. A 
molecular leak, within the system, regulates the constant volume flow rate of vapourised 
sample into the ion chamber.
In the ion source, electrons are emitted from a hot filament and are 
accelerated across the ion chamber to the collector anode. The vapourised sample 
molecules are bombarded by this stream of electrons at energies in the range 0-100eV, thus 
producing ions.
M + e' -----> M+ + 2e"
The electron energy supplied is usually higher than the ionization energy 
required to remove an electron from the highest occupied molecular orbital of the sample. 
This excess energy remains in the molecular ion and may be used to break one or possibly 
more bonds.
The ions formed are repelled out of the source using a small repeller voltage 
(< 50V), transmitted through an accelerating high potential difference (about 8 KV) between 
the source block and the accelerating slit, and then injected into a mass analyser which 
separates the ions into groups of different mass-to-charge ratios. Once this has been 
accomplished, the ions arrive at the collector, where they are detected, measured and 
recorded, either electrically or photographically. This type of measurement distinguishes 
the instrument used, either mass spectrometer or mass spectrograph, respectively.
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Most modern GC-MS instruments are smaller and cheaper than in previous 
years and need little experience to operate and maintain. They consist of a quadrupole 
analyser which has two particular advantages compared with magnetic sector instruments, 
that is, ease of data system control and small size. However, the Federal Drug Agency in 
the USA requires high-resolution MS for drug toxicology/pharmacology studies, which is 
only available with a double focusing magnetic sector instrument. Also, the sensitivity of a 
more powerful instrument may be higher and research instruments may have a number of 
facilities which provide more specificity than a smaller, routine instrument. This could be 
used to advantage for difficult analyses such as THC in whole blood.
The normal operating modes of the MS are the full scan mode and selected 
ion recording. A full scan is obtained by variation of the magnetic field between the source 
and collector slits. The scan law is;
m/z = r2H2/2V
where r is the radius of curvature through the magnetic field of strength H, and V is the 
accelerating voltage. By varying V also, ions of different m/z ratio separated by the 
magnetic field can be made to reach the collector. This is used in SIR mode to bring the 
selected m/z values into focus, thus achieving a high sensitivity since SIR focusses on a few  
ions. For instance, SIR has been used to effect the separate recording of THC and 
THCCOOH with their corresponding ^H-IS, which eluted from the GC with closely similar 
retention times. There is a limit to the mass range accessible by voltage switching of 
approximately 50% of the mass of the lowest ion monitored.
However, there is a need for specificity in SIR mass spectrometry since it 
may not be possibble for the analyser to detect a high abundance of molecular ions. By 
focussing on high masses especially with the use of derivatives, specificity could be
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enhanced. Moreover, if the resolution of the MS is increased to moderate or high 
resolution, the cross contribution between one mass and another is reduced and the 
interference from background or other sample components at the mass being monitored is 
reduced accordingly. This would achieve the specificity needed but sensitivity is lost since 
fewer ions pass through the mass analyser.
A computer control and data system is generally interfaced to the MS for 
quick data acquisition and processing. Moreover, the computer-aided instrument can 
monitor about 10-12 ions in groups at pre-set times during a GC-run.
5.2 Full Scan MS.
5.2.1 Introduction.
Selection of suitable derivatives and fragment ions for use in GC-SIR-MS 
requires an initial examination of the full spectra of the parent compound and the 
derivatives. Criteria for the selection, as mentioned earlier, are (a) intense ions at high 
mass, (b) ions free from background interference, and (c) at least two suitable ions within 
the mass range accessible by voltage switching. Also, this initial evaluation process allows 
the GC retention times of the analytes to be recorded for subsequent use in creating SIR- 
MS method files (Para. 5.3).
5.2.2 Experimental.
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5.2.2.1 Materials.
Delta-9-THC, delta-9-THCCOOH and their deuterated IS, obtained earlier, 
were prepared as before to give a concentration of lug/ml in methanol.
In addition to those chemicals and solvents previously used, Analar grade 
benzene was obtained from Rathburn Chemicals Ltd. while triethylamine was obtained 
from BDH Laboratories Ltd. The benzene was dried over calcium hydride and redistilled 
in order to remove any moisture present that would react with anhydrides. The 
derivatization reagents evaluated were trifluoroacetic acid anhydride (TFA) obtained from 
Koch-Light Laboratories Ltd., heptafluorobutyric acid anhydride (HFBA) and 
pentafluoropropionic acid anhydride (PFPA) both obtained from Pierce & Warriner (UK) 
Ltd., and pentafluorobenzyl bromide (PFB) which was obtained from Sigma Chemical Co. 
Ltd.
52 .2.2 Apparatus.
All full scan was carried out with the integrated VG 70-250S/SE system 
equipped with an HP 5890 GC and HP 7673 autosampler, described earlier. Helium was 
used as the carrier gas at a head pressure of 35kPa (5psi). The conditions for GC were as 
described earlier (Para. 3.2.2), while the scanning parameters were as listed in Table 5.1.
The MS was programmed to detect ion peaks ranging from m/z 20 to 750. 
This gave the full spectra of the compound analysed. PFK was used for calibration and 
tuning of the MS instrument.
- 7 6 -
SYS TEH1 RRR8 Parameters for Scanning acquisition CSector)
Iff Haxlmum volts 10000 I HR Haxlmum mass at 1RV 1791DAT bat a filename D'DStwT §VO Solvent delay<m*:ss> 65 66
CRL Calibration filename 18JULY COT Centroid or Top C
INS Instrument 1:70-253S HOR Heights or Rreas H
RCN Customer account HDR High dynamic range H
RCV Bcceleratlng volts 8090 P8T Probe Threshold 0 BPK
scs HRG KVE ESfl/P/S HS8 HRG CON Continuum or Hca N
HIH High mass 750 HOT Hardware tic H
LOH Low mass 80 DSC Digital scanner Y
HHI HonItor high 0 ROO Rnalogue or Digital fl
HLO HonItor low 0 HRT Store aass and time N
TRH Tic above mass 41 set ScanCEL,DU,BIH,SG) EDIS
STH Signal threshold 10 RES Instrument resolution 1000
HPU Hlnlmum peak width 6 RNO Durat LonlTlae/iScans) 1•30 00
WTH Hultlplet threshold 850 RTR RangeCRBC ,ABO RR RR RR
TIH Scan tlae<s/d,s) 1 .00 HOO Ion Hodes El- 1 — 0 -— 0
1ST InterScan timers} 0.50 GAS Gas tuPSS .
TXT DELTA-9 -TETRAHYDROCf¥t*AB1 MOL
'H*hardcopy 'T^tune PETlRN’rnext ESC*'prev NRHE*select CTRl/fl *abort
•G*go 'R*Rq*m 'R^ Rpt 'Q=qult 'C^create DEL*delete '0=overwrite T^zero
Table 5.1 : GC Scanning Parameters.
5.2.3 Preparation of Derivatives.
Trimethylsilyl derivatives were prepared by reacting 40ng of THC and 
THCCOOH with a solution (50ul) of BSTFA + 1% TMCS for 30 min at 60°C.
Fluorinated acid anhydride derivatives were prepared by combining 50ng of 
standards dissolved in 500ul dry benzene with lOOul 0.05M triethylamine in dry benzene 
and lOul of acid anhydride.(m ) The mixture was heated as above and then analysed by 
GC-MS.
Pentafluorobenzyl derivatives were prepared by mixing 50ng of standards 
with 2.0ml of dichloromethane, lOul of PFB-Br, 0.5ml of 0.4M tetrabutylammonium 
sulphate and 0.5ml of 0.8M sodium hydroxide.^ The mixture was mixed using a 
rotator for at least 30 min and the dichloromethane layer was then washed twice with 2 .0 ml 
of 0.1M sulphuric acid. Before injection, the washed dichloromethane layer was 
evaporated to dryness and reconstituted in 50ul dry benzene.
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5.2.4 Results and Discussion.
The full scan mass spectra of delta-9-THC and its derivatives, including the 
deuterated analog, are given in Figures 5.2a to 5.2g, and a summary of the fragment ions is 
given in Table 5.2.
The THC spectrum shows a prominent molecular ion at m/z 314, which is 
good for identification and SIR. The pyran ring is the centre of charge localization, and 
elimination of an electron from this nucleus gives the molecular ion m/z 3 1 4 . ( ^ )  The 
principal fragments are at m/z 299 [M-15]+ and 271 [M-43]+. The former is produced by 
the loss of a methyl group, probably from one of the geminal methyl groups attached to the 
pyran r in g ( ^ ) ,  indicating charge localization on the heterocyclic oxygen, or from the 
carbon seven (C-7) position (Figure 5.3a). The latter involves the elimination of a carbon 
at the eight position (C-8 ), both the geminal methyl groups and a hydrogen atom, either 
from the C-3 or C-5 position^ (Figure 5.3b).
Other fragments are the ion at m/z 258 [M-56]+ which corresponds to the 
elimination of a 1-butene molecule from the pentyl side chain via a McLafferty 
rearrangement (Figure 5.3c), and the ion at m/z 243 [M-15-56]+ which has been assumed to 
derive from the loss of a geminal methyl group from the [M-56]+ ion or vice v ersa /!* 2) 
Formation of ion at m/z 231 [M-83]+ appears to be important in the mass spectra of 
cannabinoids because its relative intensity varies between 30 and 100%, depending upon 
the structure of the compound/**2) Its formation mechanism is not clear due to the 
complicated structures of the many naturally occurring cannabinoids/**2) It is likely that 
the fragment contains the phenolic ring moiety of the molecule, as a corresponding 
fragment is formed for the TMS ether derivative at m/z 294 (ie at m/z 231 plus 72 amu for 
the TMS group).
- 7 8 -
Figure 5 .2 : Full Scan Mass Spectra of (a) THC (b) THCTMS (c)D3-THCTMS 
(d)THCTFA (e)THCPFP (f) THCFIFB and (G) THCPFB.
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m /z  314
OH
m /z  2 9 9
Figure 5.3a : Mechanism for the Formation of Fragment Ion [M-15]+.
(Loss o f a geminal methyl group attached to the 
pyran ring)
Figure 5.3b : Mechanism for the Formation of Fragment Ion [M-43J+.
(Elimination of a C- 8  carbon, both geminal methyl 
groups and a hydrogen atom at C-lOa position)
m /z  314 m/z  258
Figure 5.3c : Mechanism for the Formation of Fragment Ion [M-56]+. 
(Elimination of a 1-butene molecule from the 
pentyl side chain via a McLafferty rearrangement)
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The mass spectrum of THC-TMS derivative showed a high relative intensity 
of the molecular ion m/z 386. Principle fragments are found at m/z 371 and 343, 
corresponding to the elimination of -CH3  and -0 3 1 1 7 , similar to those of underivatized 
THC.
Comparison between TMS derivatives of THC and d3 ~THC showed similar 
formation of ion fragments. The fragment ions in the deuterated compound were found at 
m/z values three a.m.u. higher than in the unlabeled compound, except the [M-56]+ and 
[M-15-56]+ fragments, where their m/z values are the same, that is at m/z 330 and 315 
respectively. This is due to the removal of the 1-butene molecule from the pentyl side 
chain that contains the deuterated methyl group, thus confirming the elimination 
mechanism. Other fragments do not involve loss of the deuterated methyl group.
In addition, the mass spectra of fluorinated acyl and benzylate derivatives 
showed similar mechanisms of ion formation to those of the TMS derivative and 
underivatized THC (Fig. 5.2a-g, Table 5.2). This confirmed that fragmentation, initiated by 
charge localization, occurred favourably at the pyran or aryl rings rather than at the acyl or 
benzyl group. Hence, the derivatization process is considered to be necessary only when 
higher sensitivity and specificity is to be achieved. Moreover, if derivatisation is needed, 
TMS derivatives seem to be a good choice because the reagents are cheaper and easily 
available.
On the other hand, full scan mass spectra of THCCOOTMS and d3 ~ 
THCCOOTMS (Figures 5.4a & b) showed fragmentations similar to the THC results 
above. However, only three high intensity peaks were prominent. These corresponded to 
the molecular ions [M]+ at m/z 488 and 491; [M-15]+ at m/z 473 and 476; and [M- 
117(COOTMS)]+ at m/z 371 and 374, respectively. The former fragment is probably due 
to the loss of a methyl group as stated earlier, while the latter might be due to the
- 8 3 -
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elimination of the COOTMS group. The removal of the other derivatized group, 3'-OTMS, 
might have resulted in the formation of the weak fragment ion at m/z 397, thus showing 
that elimination of the former derivatized group is favoured. A mixed derivative, the 
methyl ester-pentafluorobenzylate was also prepared. This gave the expected ions (Figure 
5.4c) corresponding to the molecular ion (m/z 538), M-15 (m/z 523), M-carboxymethyl 
(m/z 479) and M-pentafluorobenzyl (m/z 357)
5.3 Selected Ion Recording Mass Spectrometry.
5.3.1 Introduction.
Following evaluation of the full-scan mass spectra of THC, THCCOOH and 
their derivatives, the TMS derivatives were selected for further study by SIR-MS. The ions 
selected for monitoring were the molecular ions of the cannabinoids and deuterated internal 
standards plus the corresponding M-15 and M-117 fragment ions to provide confirmation 
of the identity of the analytes in blood extracts.
5.3.2 Calibration Curves of SIR.
5.3.2.1 Procedure.
The operating conditions for the GC-MS instrument are summarised in 
Tables 5.3(a) and (b). The most intense ion peaks corresponding to the analytes, THC and 
THCCOOH, were chosen for SIR. Spiked blood samples of concentration 0, 5, 10, 20, 40, 
80, 160, and 240ng/ml were prepared with the addition of 40ul of deuterated IS. These 
were extracted according to the recommended procedure as described earlier (Para. 3.6).
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(a) * SYSTEM'HASH Param eters fo r  S e le c tiv e  Ion Recording tG t 1 KVED C Sector)
DAT Data filenam e D1THC
REF R eference filenam e PFK
INS Instrum ent 1-70-250S
RCN Customer account
ACV A cce le ra tin g  v o lts 8000 R 371.2406 ■ 50 20
RES Instrum ent re s o lu tio n 3000 B 380.9760 50 20
SAP 1Samples 1 C 386.2641 50 20
INJ t l n je c t lo n s 2 D 389.2829 50 20
GRP !Groups 2
CLS tC a l lb ra t lo n  scans 2
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CEX C al. exam ination Y
PEX Peak exam ination Y
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LST Lock s te p  Cpeak w idths) 0.02
FLO Fast lo ck  on N
IflV Maximum v o l t s
OH
10000
IflV 1773
6 T W  Mode E M S 'B a s ----------
HCamu) SCms) DCms) HCamu) SC ms) DC ms)
TXT Sample! 1> DELTfl-9-TETRflHVDROCflNNfl8INOL TMS DERIVATIVE
11 " s o r t  masses 'H»hardcopy RE TURN-next ESC**prev CTRL/A=abort 
'G»9o 'Q«<yjlt 'C ^oreate  'DEL^detete 'Q goverw rlte 'Z °zero  <group, sample>
(b) * SYSTEM:HASH Param eters fo r  S e le c t iv e  Ion R ecording [G t 2 KVEI CSect o r)
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INS Instrum ent 1-70-250S
RCN Customer account 
ACV A cce le ra tin g  v o l t s  8000
RES Instrum ent re s o lu tio n  3000 
SAP tSam ples 1
INJ # In je c tlo n s  2
GRP tGroups 2
CLS tC a l lb ra t lo n  scans 2
CST C a t. scan tim e Cs) 10
CTL C a l. to le ra n c e  Cppm) 50
CEX C a t. exam ination Y
PEX Peak exam ination Y
LMS Lock span Cpeak w id ths) 2 .0  
LST Lock s te p  Cpeak w id ths) 0 .62  
FLO F ast lock  on N
IflV Maximum v o l t s  10000
I HR Maximum mass a t IflV ___________________ 1773
GIM Time 0 !6s=30 0^08 00 Mode E I-lS  Gas
CHN PKamu) SC ms) DCms) 
A 371.2406 50 20
MCamu) SCms) DCms)
380.9760 
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20
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TXT Sample! 1< 11-N0R-9-CRR80XY-THC TMS DERIVATIVE
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'0*00 'Q -qult 'C ^create  'DEL^detete 1 Q =over*rIte '7=2600 <group ,sas»ple>
Table 5.3 : SIR-MS Operating Conditions for (a) THC and (b) THCCOOH.
Calibration curves were determined as peak area ratios of THC and THCCOOH with their 
deuterated IS, plotted against their corresponding spiked concentrations in blood samples.
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5.3.2.2 Results and Discussion.
The SIR plots for THC and THCCOOH produced linear curves from 0- 
lOOng/ml, but lost significant linearity from 100-240ng/ml (Figure 5.5). Linear regression 
analysis indicated that the correlation coefficients were 0.9896 for THC and 0.9996 for 
THCCOOH. In the latter range, values obtained were far lower than expected.
This might be due to either the lack of sample homogeneity, wrongly 
prepared sample or interference. Those errors associated with the actual MS determination 
such as stability of ion source conditions, stability of the mass scale, thresholding in the 
data acquisition, and ion statistics may also contribute to some extent. (109) However, 
sample handling and treatment accounts for the larger proportion of the sources of errors 
resulting in the sample losts. But, from the curves, it was observed that a flat plateau was 
obtained at higher concentrations which indicated a more probable cause as being a 
problem of detector saturation where the high amount of sample injected has overloaded 
the detector.
5.3.3 Case Sample Analysis.
5.3.3.1 Procedure.
The same test samples used for HPLC analyses were used again. The 
volume of each blood sample used was 0.5ml and each was spiked with 40ul of deuterated 
IS. Extraction procedure was followed as recommended (Para. 3.6).
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5.3.3.2 Results and Discussion.
Two samples were found to be positive for THC and three for THCCOOH 
(Table 5.5). When comparing the results with those from HPLC analyses, it shows that 
GC-MS by SIR is more sensitive and selective than HPLC with UV and EC detectors since 
the values obtained were higher by SIR with more samples being confirmed positive. In 
addition, SIR chromatograms did not suffer from interference by co-extracted materials, 
thus producing clean chromatograms, even though the extracts were not cleaned up prior to 
analyses.
Table 5.4 : Concentration of Cannabinoids (ng/ml) in Case Samples
Detected by SIR-MS.
Case Sample No. THC THCCOOH
1 7.4 10.3
2 1 . 2 9.7
3 - -
4 - -
5 - -
6 - -
7 - -
8 - 5.4
Not detected
- 8 9 -
5.4 Metastable Ion/Multiple Reaction Monitoring.
5.3.1 Introduction.
Generally, there are three types of fragment ions that may be detected by MS 
equipped with magnetic analyzers. These are the molecular ions, daughter ions and 
metastable ions. Molecular ions are transmitted intact through the MS. Meanwhile, 
daughter ions arise by fragmentation of the molecular ions or by decomposition of other 
daughter ions in the ion source region. They are then transmitted through the instrument.
M+ — > d j+ + d2
d l+ - ~ >  d3+ + d4
However, metastable ions only arise when ions dissociate in one of the three 
field-free regions after leaving the source but before reaching the collector of the 
instrument (Figure 5.1). The three field-free regions are situated before the first analyzer, 
between the two analyzers, and after the second analyzer. These regions are so called
because ions are not acted on by either magnetic or electric fields, but are moving linearly
through the regions. In the present study, only metastable ions formed in the first field free 
region were examined.
Metastable ion monitoring involves the adjustment of the electrostatic 
analyser voltage and magnetic field to the point where daughter ions formed in a metastable 
transition in the first field free region are brought into focus at the collector. Other 
fragment ions, including those arising from endogenous contaminants by different 
fragmentation mechanisms, are trapped by the electrostatic analyser leaving an almost clean 
background.
- 9 0 -
Three types of metastable ion reactions can be selectively measured by the 
appropriate selection of the instrumental parameters. The reactions are (1) daughter ions 
originating from a specified parent ion, (2 ) all parent ions producing a specified daughter 
ion, and (3) all transitions of specified neutral fragment loss characteristic of a particular 
compound class. The scan laws are as follows;
Daughter H/E = Constant 
Parent H2/E = Constant 
Constant Neutral Mass Loss H/E [1-E/EJ1/2 = Constant
where H and E are the magnetic field strength and electroststic sector voltage respectively, 
while EQ is the corresponding value of a normal ion when the instrument was tuned before 
analysis.
The measurement of metastable ions in an MS provides information related 
to the structure of the ions and the structure of the compounds from which they originate. 
This information will provide a fingerprint spectrum for a specific compound which may be 
recorded, even in the presence of a matrix giving many other ions, in the normal spectrum. 
Thus, its application can provide a more specific and sensitive structural probe especially 
for the differentiation of isomers. Moreover, a sample component may be detected with 
high sensitivity by monitoring selected metastable ions.
5.4.2 Experimental.
- 91  -
5.4.2 . 1  Materials.
All solvents and chemicals were obtained as before and all standards were 
prepared as previously described (Para. 3.2.1). Trimethylsilyl derivatives of standards were 
prepared as described earlier (Para. 5.2.3).
5.4.2.2 Apparatus.
All conditions on the VG 70-250S/SE system were the same (Tables 5.3 and 
5.4) except that the MS was used in the multiple reaction monitoring (MRM), programmed 
to detect the transitions m/z 386.26 to 371.24 for delta-9-THC and m/z 488.28 to 473.25 for 
delta-9-THCCOOH.
5.4.3 Metastable Scan.
Metastable spectra were recorded in full scan mode for daughter ions formed 
from the molecular ions of THCTMS and THCCOOTMS. The spectra obtained (Figures 
5.6a & b) showed many fragment ions but only the daughter ion [M-15]+ peak at m/z 371 
and 473 respectively, was prominent. Hence, the transition M+ - >  [M -C ^ ]*  of the TMS 
derivative was chosen for further analysis. Moreover, previous work has indicated that this 
derivative gives the best GC-MS characteristics.(114)
- 9 2 -
5.4.4 Calibration Curves for Metastable Ion Monitoring.
5.4.4.1 Procedure.
Deuterated IS (40ng) was added to spiked blood samples of concentrations 
0, 5, 10, 20, 40, 80, 160, and 140ng/ml. These were extracted as recommended (Para. 3.6) 
and derivatized with TMS (Para. 5.2.3). Calibration curves were determined as peak area 
ratios of THCTMS and THCCOOTMS with their deuterated IS, plotted against 
corresponding spiked blood concentrations.
5.4.4.2 Results and Discussion.
The plots produced linear curves from 0-100ng/ml, but lost significant 
linearity from 100-240ng/ml (Figure 5.7). Linear regression analysis indicated that the 
correlation coefficients were 0.9988 for THC and 0.9977 for THCCOOH. Results obtained 
were similar to those of GC-SIR-MS. Values at the higher range were lower than 
anticipated, showing again that apparent sample losses were occurring at spiked 
concentrations of 100-240ng/ml. This loss of linearity is probably due to detector 
saturation where the high concentration of the sample injected has overloaded the dynamic 
range of the analogue-to-digital converter used in the detector/computer interface.
Figure 5.6 : Metastable Scan Mass Spectra of (a) THCTMS and (b) THCCOOTMS.
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5.4.5 Case Sample Analysis.
5.4.5.1 Procedure.
The same case samples used for HPLC and GC-SIR-MS analyses were used 
again. Each blood sample (0.5ml) was spiked with 40ng of deuterated IS. The extraction 
procedure was followed as recommended (Para. 3.6).
5.4.5.2 Results and Discussion.
It was observed that most of the THC-metastable peaks had interference, 
resulting in inaccurate quantitation of the cannabinoid. Three samples were found to be 
positive for THC and THCCOOH (Table 5.6). For THC, MRM gave higher calculated 
levels than SIR, but the opposite was found to be true for the metabolite. This is because 
the test samples, which might contain certain endogenous compounds having similar 
extractive and analytical properties to THC in giving [M-CH3 ]+ fragments, were not 
submitted to the clean-up procedure prior to GC-MRM-MS analyses.
More samples could have been confirmed positive if not for the presence of 
co-extracted interference. However, the interference did not occur under SIR or even 
during the calibration curve determinations. Hence, the clean-up procedure was found to 
be necessary for detection of cannabinoids in blood samples by MRM, although Harvey et 
al(58) had reported earlier that sample clean-up was not required for their cannabinoid- 
metastable ion detection in plasma samples.
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Table 5.5 : Concentration of Cannabinoids (ng/ml) in Case Samples Detected by
Multiple Reaction Monitoring.
Test Sample No. THC THCCOOH
1 9.1 8.4
2 5.2 8 . 8
3 2 . 8 -
4 * -
5 - -
6 * -
7 * -
8 * 2.4
Not detected 
* Interference
Another way to exclude any interference is to monitor other transitions, 
although they are not prominent. For instance, the fragment [M-56]+ corresponding to the 
elimination of a 1 -butene molecule from the pentyl side chain could produce a cleaner 
chromatogram since not many endogeneous compounds will have the same side chain 
giving rise to a similar fragmentation pattern.
-91  -
5.5 Negative Ion Chemical Ionisation.
5.5.1 Introduction.
Chemical ionisation (Cl) occurs when sample molecules are ionized by a 
chemical reaction (charge transfer) rather than by electron bombardment. The technique 
requires a high pressure of a reagent gas (e.g. methane, isobutane, ammonia) in the ion 
source and the gas molecules are usually present in high concentration compared to the 
sample molecules, in order to minimize the occurrence of any electron impact ionisation.
The principal applications of Cl derive from its ability to produce 
information about the molecular weight of compounds analysed and their structural and 
stereochemical information, where EI+ often fails to do s o . ( ^ )  Moreover, the structural 
information obtained can be controlled by varying the reagent gas used since the 
characteristics of the Cl mass spectrum produced are highly dependent on the nature of the 
reagent gas used to ionize the sample.
There are two types of Cl, positive ion (Cl or PICI) and negative ion (NICI). 
Both ions are formed during an ionization process, but the negative ions usually remain 
undetected because ion source and focussing potentials allow only the extraction o f positive 
ions from the source. The total ionization in PICI is at least an order of magnitude less than 
that recorded by EI+, and the sensitivity of NICI is several orders of magnitude lower than
piCi.(109)
Negative ion (NICI) normally occurs by electron capture (associative 
resonance AB + e" —> AB" and dissociative resonance AB + e" — > A' + B ) and ion 
pairing (AB + e" —> A+ + B" + e') mechanisms. Reagent ions are formed in the source by 
electron bombardment of suitable reagent gases which will then react chemically with 
sample molecules to form negative ions. In order to achieve detection limits in the low
- 9 8 -
femtogram ( 1 0 " ^ g )  region, the sample must naturally possess or acquire through the 
preparation of a suitable derivative, a positive electron affinity. (1 ^ )  However, trace 
quantities of impurities with high electron affinities (for example, molecules containing 
halogens) can seriously deplete the population of electrons in the ion source available for 
sample ionization, thus a sharp drop in sample sensitivity will result.^ ^ )
In the present study, ammonia was chosen as the reagent gas because proton 
transfer from N H ^  is restricted to compounds with a proton affinity greater than that of 
ammonia, although methane and isobutane too contribute very little to the 
background.(109) For comparison purposes, the isobutane NICI mass spectra were also 
examined, as were the effects of the electron energy.
5.5.2 Experimental.
5.5.2.1 Materials.
Standards were prepared as before to give a concentration of lug/ml in 
methanol. Similarly, chemicals, solvents and derivatization reagents were obtained and
used as before.
5.5.2.2 Apparatus.
GC-NICI-MS was carried out with the same integrated VG 70-250S/SE  
system equipped with an HP 5890 GC and HP 7673 autosampler. The conditions for GC 
were as described earlier (Para. 3.2.2).
The MS was used in the negative ion chemical ionisation (NICI) mode using 
ammonia and isobutane as reagent gases. Full scan mass spectra in NICI mode were
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recorded at the mass range m/z 700-20 for the TFA, PFP, HFB and PFB derivatives of 
THC. The mass spectrum of the TFA derivative was recorded at 70eV and 32eV to assess 
the effect of electron energy on the fragmentation pattern. In the selected ion recording 
mode, the instrument was programmed to detect ion peaks at m/z 410 for THC-TFA, 460 
for THC-PFP, 494 for THC-PFB, and 510 for THC-HFB. Ammonia was used as the NICI 
reagent gas in the SIR mode at a source pressure and temperature of 1x10"^ torr and 
180°C, respectively. The photomultiplier was set at 500 Volts and NICI spectra were 
recorded at an ionization energy of 70eV. PFK was used again as a mass marking 
calibrator for daily calibration. Tuning of the MS instrument in the negative ion mode was 
conducted using PFK at m/z 331.
5.5.3 Full Scan NICI Mass Spectra.
Full scan NICI spectra were recorded for the TFA, PFP, HFB and PFB 
derivatives of delta-9-THC to permit selection of suitable prominent negative ions for 
quantitation of THC by NICI selected ion recording. The results (Figures 5.8a - d) showed 
that PFB derivative gave stronger high mass negative ions than the other derivatives in 
which the most prominent ions were characteristic of the acyl fragment and not the 
cannabinoid molecule. This was true for both ammonia and isobutane reagent gases. 
For one derivative, THC trifluoroacetate, the electron energy was reduced to 32eV to try 
and reduce the degree of fragmentation but this had little or no effect on the intensity of the 
high mass ions. Thus, in view of its sensitivity, PFB derivatization was used for further 
NICI analysis.
In the present initial assessment, only delta-9-THC was examined. The bis- 
derivatives of THCCOOH could not be detected, presumable because of their high 
molecular weights. The mixed derivative (methyl ester-pentafluorobenzyl derivative)
(b)
(c)
(d)
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Figure 5.8 : Full Scan NICI Mass Spectra o f (a) THCTFA 
(b) THCPFP (c)THCHFB and (d) THCPFB.
^
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would be suitable but requires the use of diazomethane for the preparation of the ester. 
Alternate esterification reactions, for example, using BFymethanol were evaluated briefly 
but were found to be unsuccessful substitutes for diazomethane. In view of the hazards of 
this material, the mixed derivative was not examined further in this pilot study.
5.5.4 Calibration Curve for NICI Selected Ion Recording.
5.5.4.1 Procedure.
Spiked blood samples of concentration 0, 1,5,  10, 20, 40, 80, and 160ng/ml 
were prepared with the addition of 40ng deuterated IS. These were extracted as 
recommended (Para. 3.6) and derivatized with PFB-Br (Para. 5.2.3).
5.5.4.2 Results and Discussion.
The SIR traces obtained showed severe interference due to co-extracted 
interferences (Figure 5.9a to 5.9d). None of the spiked blood samples could be used for 
calibration curve determination. This observation showed that a clean-up procedure for 
blood extracts is necessary for NICI analysis.
5.5.5 Case Sample Analysis.
5.5.5.1 Procedure.
Two of the test blood samples that gave positive results under MRM were 
analysed used under NICI mode. The test samples (0.5ml) were mixed with 40ng of
- 102-
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Figure 5.9 : NICI-SIR Chromatograms o f (a) THCPFB 20ng/ml Std. 
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deuterated THC and were then extracted and derivatized with PFB-Br, as recommended. A 
lul aliquot was injected into the GC-MS system.
5.5.5.2 Results and Discussion.
Both test samples, no. 1 and 2, showed THC GC peaks. Unfortunately, the 
latter had the THC peak at a shoulder of an interference peak while in the former, the THC 
peak could not be quantified since the preparation of a calibration curve was unsuccessful 
(Figure 5.10). Thus, the NICI method, although it is sensitive and selective, was not found 
to be particularly useful due to presence of co-extracted materials, unless the samples were 
cleaned up prior to analysis.
5.6 Conclusion.
The purpose of this GC-MS study was to select the best detection method for 
the quantitation of THC and THCCOOH in autopsy blood without extensive sample clean­
up. Results obtained showed that only selected ion recording at moderate resolution under 
the electron impact ionisation mode gave good SIR chromatograms, free from interference. 
Other detection methods including metastable ion monitoring and negative ion chemical 
ionisation SIR, produced chromatograms which were unsatisfactory due to the presence of 
co-extracted interferences. Further studies must be conducted, especially with sample 
clean-up prior to analysis, before these methods can be utilised.
Consequently, a GC-MS method for the analysis of cannabinoids in blood 
samples has been established using the selected ion recording mode. This method is 
recommended for daily analysis because it was proven to be sensitive and selective, to need 
only a small sample volume and to be suitable for the automated analysis of batch samples.
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Figure 5.10 : NICI-SIR Chromatograms of Case Samples.
(a) Case No. 1 and D3-THCPFB 20ng/ml IS.
(b) Case No. 2 and D 3-THCPFB 20ng/ml IS.
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CHAPTER 6 ; CONCLUSIONS.
6.1 AIM OF STUDY.
Cannabis has been widely known for both its narcotic qualities and its fiber 
for thousand of years. It is undoubtly the most widely misused drug in UK and most of the 
people who have ever used any illegal drug have used cannabis. From the British Crime 
Survey^ ^  conducted in 1981, it was found that 5% of 16,000 people interviewed 
admitted having used cannabis. In addition, according to a 1982 Household Survey done 
by the US Department of Justice, there are about 20 million annual users and about 4 
million daily users, most of whom are adolescents and young adults.(^7)
Detection of cannabis in body fluids provides unquestionable evidence of its 
misused. Many methods have been developed and are widely used routinely, especially for 
the detection of the psychoactive component delta-9-tetrahydrocannabinol (delta-9-THC) 
and its major metabolite, ll-nor-9-carboxy-delta-9-tetrahydrocannabinol (delta-9- 
THCCOOH) in urine samples. However, only few have dealt with routine screening and 
subsequent confirmatory analysis in whole and hemolysed blood samples. This is because 
blood samples often contain co-extracted lipid materials that give rise to interferences. 
Moreover, it is difficult to extract the cannabinoids from blood proteins and inhomogeneous 
samples will lead to unreliable results. Thus, it is a challenging problem for the forensic 
toxicologist to use blood samples for the detection of cannabinoids.
Modern analytical and instrumental techniques provide an opportunity to 
detect low levels of cannabinoids in body fluids. However, funds are usually restricted and 
often unavailable, especially for developing countries, to set up a modem well-equipped 
laboratory, making their forensic work restrictd in its range of capabilities. An alternative 
to costly techniques is needed.
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In the present study, high-pressure liquid chromatography (HPLC) and gas 
chromatography-mass spectrometry (GC-MS) were chosen for evaluation. The former was 
used with ultra-violet (UV) and electrochemical (ECD) detectors. Although both detectors 
are non-specific, ECD will provide the sensitivity needed. The latter was used under full 
scan, selected ion recording (SIR), metastable ion monitoring (MRM) and negative ion 
chemical ionisation (NICI) modes which are specific and sensitive. Gas-liquid 
chromatography with electron capture detector was not available for evaluation.
A sample preparation procedure has been established. However, the extra 
clean-up step was only used for the non-specific end-step analysis while for GC-MS 
analysis, the step was omitted. The use of diatomaceous earth (Extrelut), although quicker 
than solvent extraction, was found to be useless. It has been found to give good 
reproducibility and recovery with other drugs such as morphine and amphetamines, but it 
did not work with cannabinoids. Perhaps the log K (partition coefficient of THC between 
octanol and water, i.e. the lipid solubility) is too high for effective extractions to be made.
Many clean-up procedures have been reported. However, the use of solid- 
phase extraction (SPE) tubes are more favourable than the lengthy liquid-liquid extraction 
procedures. SPE has the advantages of rapid sample preparation, especially batch samples, 
prevention of emulsion formation and potential automation. Recently, Bond Elut Certify II 
SPE tubes have been developed specially for the extraction and purification of 
cannabinoids from biological samples. Availability of these tubes, which were 
incorporated in this study, provide a clean and quick clean-up procedure. New  
developments in this field must be pursued in order to offer analysts a unique SPE which 
can give high drug recoveries, complete removal of interfering materials and rapid sample 
preparation times.
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The quality of results obtained by HPLC and GC-MS analyses were 
compared. The former under both detection methods showed cleaner chromatograms for 
the THC fraction but the metabolite fraction contained many nearby co-extracted materials. 
GC-MS, on the other hand, under selected ion recording electron impact mode gave good 
SIR chromatograms, free from interferences. Other detection modes showed interferences 
and gave unsatisfactory results. None of these detection systems gave any false negative 
result but HPLC was found to give false positive results for the cannabinoids. Moreover, 
GC-MS provided the accuracy and precision needed, whereas HPLC was found to give 
large variation of calculated results with low precision.
From the above observations, it was concluded that GC-MS under SIR-EI+ 
mode can provide the reliability of end-step detection needed for legal purposes. But, 
whether it can be used routinely by an inexperienced analyst to give reproducible, reliable, 
accurate and precise results is yet to be questioned.
6.2 FUTURE WORK.
Further studies need to be performed to provide the most sensitive and 
selective method for routine screening and subsequent confirmatory of cannabinoids in 
blood samples. Rapid single step sample preparations are needed, especially with the 
development of unique solid-phase extraction tubes, which can separate the cannabinoids 
efficiently from a blood matrix.
Evaluation of HPLC detection systems must be extended with the addition 
of a more specific and sensitive detector such as a fluorescence detector which is very 
selective when a fluorescence derivative is being used. Gas chromatography can also be
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utilised as an end-step analysis. It will provide a very sensitive method when electron 
capture or nitrogen phosphorous detector is employed with the use of suitable derivatives.
Other sophisticated and rapidly growing mass spectrometry techniques such 
as LC-MS and MS-MS can also be evaluated. The former does not require any 
derivatization while the latter does not need any clean-up or chromatography. However, 
LC-MS is less sensitive than GC-MS with current instrumentation. Moreover, problems 
associated with interfacing both systems have been recognised. Introduction of samples 
using a direct probe technique makes MS-MS a very sensitive instrument, but its use is 
restricted mainly for research studies due to the high costs and the expertise needed to 
operate it.
Whatever future methods are developed and used for the detection of 
cannabinoids in blood samples, must be sensitive and specific. The techniques can either 
utilise a very sensitive instrument such as GC-MS or two independent non-specific 
techniques like radioimmunoassay and HPLC. But, it must give reliable results which the 
expert can confidently present in the court of law.
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